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INTRODUCTION 
Few clinical problems have received as much attention as the re­
lationship between cholesterol and cardiovascular abnormalities, 
especially with regard to increasing age. A decrease in cardiac output 
has been found to occur with age (Bender, 1965). Elevated serum and 
tissue lipid levels, which increase with age (Carlson £t a^., 1968), 
have been correlated with an increased incidence of cardiovascular 
disease (Stamler, 1967). 
Thyroid hormone influences the cardiovascular system (Freedberg and 
Hamolsky, 1974). Hyperthyroidism shows cardiac hyperactivity, eg. 
increased cardiac output and heart rate, while hypothyroidism shows the 
opposite. There is also a decrease in peripheral resistance with 
hyperthyroidism. Beznak (1962) found the enlarged hearts of thyroxine-
treated rats to be stronger and to have a greater reserve. 
Cholesterol metabolism is also influenced by thyroid hormone 
(Kritchevsky, 1960 and Myant, 1964). The metabolic processes involved 
in cholesterol metabolism appear to be increased in hyperthyroidism 
and decreased in hypothyroidism. The resulting decreased lipid levels 
in the hyperthyroid state and increased levels in the hypothyroid state 
are thought to be due to a greater influence on the catabolic processes 
involved in cholesterol metabolism. 
A possible factor involved in the age related changes in the 
cardiovascular system and cholesterol metabolism is the decreased 
thyroid secretion rate of old animals (Grad and Hoffman, 1955, and 
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Story, 1972). 
Chronic exercise has been associated with advantageous effects on 
the heart and as a possible deterent to atheroselerosis (Froelicher, 
1972). Decreased lipid levels have been related to exercise in man 
(Mann et al., 1955) and in animals (Jones £t £l., 1964). In a possible 
association with these findings chronic exercise has also been found to 
increase the thyroid secretion rate (Irvine, 1967, and Story, 1972). 
This study was designed to investigate the effects of age, exercise 
and varying thyroxine levels on several cardiovascular parameters and 
cholesterol turnover pools in the rat. Two separate studies were under­
taken to investigate first the cardiovascular parameters and second the 
cholesterol turnover pools. 
The cardiovascular changes studied were heart weight, heart rate, 
blood pressure, blood flow through the abdominal aorta and peripheral 
resistance. Conventional methods were used to measure each parameter, 
with an electromagnetic flowmeter utilized for the blood flow measure­
ments. 
The turnover of serum cholesterol was investigated using the method 
of Goodman and Noble (1968), which involves analysis of the decay curve 
resulting from the single intravenous injection of radioactive 
cholesterol. 
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REVIEW OF LITERATURE 
The REVIEW OF LITERATURE will be divided into two basic parts, that 
concerning the cardiovascular system and that concerning cholesterol. 
A complete review of each will not be attempted; instead, emphasis will 
be placed upon the effect of the parameters involved in this study: 
thyroxine, exercise and age. 
Cardiovascular System 
Cardiovascular system in relation to thyroxine 
The relationship between the heart and altered thyroid gland func­
tion was first noted by Caleb Hillier Parry in 1786, and thus predated 
by 14 years Joseph Flajani's publication in 1800. Parry's account was, 
of course, made several years before the classic description of Robert 
Graves and Karl von Basedow (Willius and Keys, 1941). Since that time i 
numerable accounts have been made on. the relationship, and to this day 
there is still controversy on the mechanism of its action. 
Patients with hyperthyroidism have been found to have increases 
in the following characteristics: heart rate, cardiac output, mean 
systolic ejection rate, pressure time per minute, left ventricular work 
and stroke power; and shortening of the following: left ventricular 
ejection time, preejection period and isovolumetric contraction time 
(Pietras et al., 1972). In the hyperthyroid state cardiac output is 
increased from 50 to 200 percent, the rise in output generally being 
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greater than the increase in oxygen consumption. The difference between 
arterial and mixed venous oxygen is smaller than normal. ' The average 
blood flow increase is also greater than the change in oxygen consump­
tion. Mean blood pressure is slightly subnormal, and systemic resistance 
is markedly below normal (Freedberg and Hamolsky, 1974). The hemo­
dynamic changes with hypothyroidism are opposite to those found in 
hyperthyro idism. 
In animals the changes in the cardiovascular dynamics are similar 
to those seen in man. Beznak (1962) gave rats increasing doses of 
thyroxine for one to seven weeks. With the larger doses she reported 
increases in oxygen consumption, cardiac output, cardiac hypertrophy, 
and cardiac work. 
With thyroxine some authors have felt that cardiac hypertrophy 
occurred only when there was co-existent organic heart disease (Kepler 
and Barnes, 1932; Friedberg and Sohval, 1937), while others have be­
lieved that hypertrophy might result solely from excessive thyroid 
hormone activity (Parkinson and Cookson, 1931). Subsequent work has 
clearly shown that experimental hyperthyroidism is accompanied by cardiac 
hypertrophy in the rat, guinea pig, mouse, cat, rabbit and dog (Gemmill, 
1958; Golber and Kandror, 1969; and Van Liere and Sizemore, 1971). 
Cohen et. JLL' (1966) have shown an increased incorporation of 
leucine - into total myocardial protein in mice within 48 hours 
after thyroxine administration. It was also noted that the permissive 
requirement of growth hormone on the thyroid hormone effect on heart 
growth (Beznak, 1962) may be important, however, the findings of 
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Tipton and Tcheng (1971) do not support this hypothesis. The chemical 
composition of the ventricle changes with a 50 percent increase in 
actomyosin. The noncontractible protein and ventricular weight in­
creases to a lesser extent, 41 and 36 percent, respectively (Inchiosa 
and Freedberg, 1965). Similarly, Bartosova et al., (1969) found that 
thyroxine increased heart size, but had much less effect on collagen 
synthesis. Hypoxia or isoprenaline administration increased only the 
growth of collagen, and in other forms of cardiomegaly, like exercise, 
muscle and collagen formation were stimulated to the same extent. 
Mowery and Lindsay (1973) found a proportionately greater hypertrophy 
of the right ventricle than in the left, and, like Bartosova, the 
changes in heart weight were predominately a reflection of substances 
not containing hydroxyproline. 
The biochemical mechanisms involved in the hypertrophic response 
of the heart in hyperthyroidism are not well understood. Studies of 
cardiac mitochondrial function after ithyroxine administration have been 
reported (Tarjan, 1971; Zaimis ^  al., 1969). A hypothesis has been 
proposed that the thyroxine-facilitated oxidation of fatty acids and 
relative retardation of pyruvate oxidation renders carbohydrate more 
available for the synthesis of nucleotides, nucleic acid and protein. 
Whether these alterations in cardiac mitochondria in hypothyroidism are 
in the opposite direction, and whether there are changes in mitochondrial 
function and protein synthesis in congestive heart failure due to 
thyrotoxicosis remain to be determined (Freedberg and Hamolsky, 1974). 
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The effect of thyrotoxicosis on heart rate has long been known. 
Caleb Parry (Willius and Keys, 1941) wrote in 1786 about a woman with 
an enlarged thyroid gland; 
"...each sytole of the heart shook the whole thorax. 
Her pulse was 156 in a minute, very full and hard, alike 
in both wrists, irregular as to strength, and inter­
mitting at least once in six beats." 
Until recently it was widely accepted that enhanced responsiveness 
to catecholamines was a typical feature of hyperthyroidism (Harrison, 
1964); and that the resting tachycardia of this disease was due to 
excessive sensitivity of the pacemaker to adrenergic stimuli (Brewster 
e^ al., 1956). However, in the past six years several careful studies 
indicate that there is no increased sensitivity to catecholamines in 
the hyperthyroid rat, dog, cat or human (Van der Schoot and Moran, 1965; 
Wilson et a^., 1966; Anton and Gravenstein, 1970). These studies and 
others have led to the more current view that the tachycardia of hyper­
thyroidism is due mainly to a direct effect of thyroxine on the sino­
atrial node, which is not mediated by catecholamines. 
Pietras et al., (1972) has reported data which suggests that the 
hyperdynamic circulatory state in hyperthyrodism results from the combina­
tion of the direct action of thyroxine on the myocardium and the activa­
tion of the beta-adrenergic receptors. 
To complete the current picture of possibilités researchers 
(Heimbach and Crout, 1972; Shimada and Oshima, 1973) reported data that 
are interpreted as suggesting that the resting tachycardia of 
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hyperthyroidism is due to the combination of a direct rate-increasing 
effect of thyroxine on the sinoatial node and an inçairment of vagal 
inhibition of heart rate. 
The effects of various levels of thyroid activity on the heart may 
be postulated to be due to one, or a combination, of the following 
mechanisms: 1) the participation of the heart in increased or de­
creased general body metabolism; 2) the servo adjustment of the myo­
cardium to fulfill the general body requirements of blood flow and 
oxygen consumption; and 3) the direct, or indirect, effect of the 
thyroid hormone on the cardiac muscle regardless of any other influence 
(Amidi e^ , 1968). Much evidence supports the last postulate. 
Hyperthyroidism affects the intrinsic contractile state of the 
cardiac muscle primarily by altering the speed of shortening of the 
contractile element. Âmidi et a^., (1968) reported more shortening of 
isovolumic contraction time and ejection time in hyperthyroid and more 
prolongation of these intervals in hypothyroid subjects. Amidi also 
found that catecholamine depletion with reserpine failed to alter the 
hemodynamic findings of hyperthyroid subjects toward normal. Freedberg 
et al., (1970) reported that the duration of the repolarization phase 
of the action potential was greatly prolonged in atria from thyroid-
ectomized rabbits, and was shorter in hyperthyroid atria. The resting 
potential and action potential heights were not affected by differences 
of thyroid state. These changes could account for a reduced probability 
of arrhythmias in hypothyroidism, and the converse in hyperthyroidism. 
The findings of Braunwald e^ a^., (1969) suggest that the alterations 
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in cardiovascular dynamics observed in the intact organism with hyper -
or hypothyroidism do not result merely from changes in the load placed 
upon the myocardium by induced alterations in the metabolism of the 
extra-cardiac tissues, but that they result, in part at least, from 
direct effects of thyroid hormone on the intrinsic contractile behavior 
of the myocardium. 
There is evidence, however, for an interrelationship between 
catechols and thyroid state in cardiac contractility. Freedberg and 
Hamolsky (1974) reported a depressed left ventricular maximal dp/dt 
response to isoproterenol in the hypothyroid dog, compared with 
euthyroid or with T^- treated dogs. Maximal dp/dt was unaffected by D-
or L-Tg alone. 
The increased contractility in hyperthyroidism has been related to 
increased myocardial myosin adenosine triphosphatase (ATPase) activity 
There has been shown to be an early (24 hours after T^) effect on 
maximal rate of tension development, however, time to peak tension does 
not shorten for at least eight days after thyroid administration. 
Apparently the early effects of T^ are an excitation contraction 
coupling, and the later effects result.from an increase in muscle mass 
(Freedberg and Hamolsky, 1974). 
The mechanism of the increased contractility in hyperthyroidism 
and its opposite in hypothyroidism have not been established. Under­
standing awaits clarification of the contractile mechanism itself and 
further understanding of the mechanism of action of the thyroid hormones 
on the heart and body. Changes in excitation contraction coupling. 
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calcium transport effects, the interaction of calcium with cyclic 3*, 
5'-adenosine monophosphate and in the number or nature of functioning 
contraction units are among the possibilities that require further study 
(Freedberg and Hamolsky, 1974). 
The physiological mechanisms of the seemingly direct thyroxine 
effects have not been established. A variety of metabolic actions have 
been ascribed to thyroxine in heart and other tissues, including: 
1) effects on synthetic processes (Sokoloff £t aj^., 1968 Tata, 1970); 
2) mitochondrial function (Hoch, 1971); 3) certain pathways of inter­
mediary metabolism (AltsChuld £t al^., 1969; Lee and Hsu, 1969; Paterson, 
1971) ; 4) the adenyl cyclase system (Levey and Epstein, 1969); 
5) membrane Na^-K"'"-ATPase (Ismail-Beigi and Edelman, 1971); and 6) the 
effect on myocardial ATP stores (Cohen et al., 1973). These mechanisms 
will be discussed briefly. 
1) Sokoloff et al., (1968) reported that a single dose of tri-
iodothyroxine to an euthyroid animal stimulates liver protein synthesis 
within less than two hours. It is suggested that the stimulation of 
protein synthesis by thyroid hormones vivo consists of two components: 
a) an initial, cytoplasmic mitochondria - dependent stimulation of the 
existing protein synthesizing apparatus, followed by, b) a secondary, 
nuclear - mediated, cellular response or adaptation which leads to an 
increase in the amount of protein synthesizing machinery. 
Kaplay and Sanadi (1971) found that thyroxine given to hypothyroid 
rats causes the formation, within a few hours, of a "specific" mito­
chondrial protein. When this protein is extracted and incubated 
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in vitro with hypothyroid mitochondria, it augments state four respira­
tion (oxygen, consumption with ATP, but without substrate). 
The effects on synthesis of macromolecules have been studied by 
Tata (1970) and Tata and Widnell (1966). They found that thyroxine 
administration leads to an increase in liver nuclear RNA polymerase 
activity in 8 to 12 hours, subsequent increases in RNA synthesis in 20 
to 40 hours and later increases in cytoplasmic protein synthesis. 
2) Thyroxine administration in animals leads to a dramatic increase 
in the number of mitochondria, their size and the complexity of their 
internal structure, with many more cristae being apparent. Hoch (1971) 
suggested a direct effect of thyroxine on mitochondrial respiration. 
He found an increase in state four respiration in 30 minutes to three 
hours after injection of thyroid hormone to hypothyroid rats. 
3) Altschuld £t al., (1969) postulated that an inhibitor of 
phosphofructokinase (PFK) which resides dominantly in the particulate 
fraction is probably responsible for the diminished anaerobic glycolysis 
and performance of the hyperthyroid heart. In contrast to the hyper­
dynamic cardiac performance in the aerobic state with excess thyroid 
hormone, in the anaerobic state the effects of excess thyroid hormone 
are diminished performance and metabolism. 
A study by Path and Kako (1973) demonstrated the major role of 
PFK in the control of glycolytic flux in all thyroid states. The 
activity of PFK may be the limiting step in hyperthyroid hearts. 
In contrast, in arrested euthyroid hearts, an increased level of citrate 
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is more likely the cause of PFK inhibition. 
Lee and Hsu (1969) found that alpha-glycerophosphate dehydrogenase 
activity in liver and kidney mitochondria increased three-fold in 24 
hours after a single dose of L-triiodothyroxine. The hormone produced 
a small, but significant, increase in the activity of heart mitochondria. 
This enhanced activity probably results from the biosynthesis of new 
enzyme protein. 
It was concluded by Paterson (1971) that the function of the thyroid 
gland may be of importance in maintaining an adequate cardiac glycolytic 
activity in ischaemic conditions, in terms of maintaining cytoplasmic 
NÀD levels. And also in promoting tissue repair after such attacks by 
increasing pentose phosphate pathway activity. 
4) Levey and Epstein (1969) have shown that catecholamines, 
throxine and glucagon all stimulate adenyl cyclase vitro in cat 
ventricular homogenates. Epinephrine and thyroxine have additive effects 
on cyclic AMP accumulation, indicating that there are probably two 
separate receptors and adenyl cyclase systems for these hormones. It 
must be noted however, that myocardial adenyl cyclase is reported to 
be normal in hyperthyroid animals (Sobel et al., 1969), that myocardial 
adenyl cyclase sensitivity to epinephrine is not increased in thyro­
toxicosis and that myocardial cyclic AMP levels are not augmented in 
thyrotoxic animals (McNeill et aj^., 1969). 
5) Ismail-Beigi and Edelman (1971) reported results which indicate 
that thyroid hormones stimulate NaK-ATPase activity differientially. 
There was a higher percent of activity in the liver of euthyroid rats 
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than from hypothyroid rats, but a lower percentage in euthyroid than 
hypothyroid rats in the kidney. The results also indicate that the 
dominant effect is on the Na"*" pump. 
6) A conserving effect by thyroxine on the ATP control of rat 
atria, incubated under conditions of limited oxygen availability has 
been demonstrated by Cohen ^  al., (1973). It was suggested that 
thyroxine can increase the availability of useful energy under these 
conditions, as reflected in the effect of decreased lactate production 
and in accelerated protein synthesis. 
Systemic resistance (mean arterial blood pressure divided by the 
cardiac output) is decreased in hyperthyroidism and increased in hypo­
thyroidism. It could be a significant determinant of the increase in 
cardiac output in hyperthyroidism (Treedberg and Harmolsky, 1974). 
It has been reported that the vasodilation present in hyper­
thyroidism and the vasoconstriction in hypothyroidism may be associated 
with the alpha adrenergic response of arteries (Theilen and Wilson, 
1967; Rosenquist and Boreus, 1972; Zaimis et, fl." » 1965; Kontos et al., 
1965). Rosenquist and Boreus suggest that the hypothyroid state shifted 
the balance between the alpha and beta adrenergic receptors, and in­
creased the alpha adrenergic response of the tissue. Venomotor tone 
was not found to be altered in thyrotoxicosis (Frey, 1967). 
The results of Field et al., (1973) partly supports the above 
suggestion. Aorta from hyperthyroid and hypothyroid rats were super­
sensitive and subsensitive, respectively, to low doses, of norepine­
phrine and the rates of relaxation were slower and faster, respectively. 
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However, similar alterations to KCl sensitivity occurred. This suggests 
that thyroid hormone does not alter vascular response by acting 
specifically at the adrenergic receptor. 
Cardiovascular system in relation to exercise 
Hypertrophy of the heart due to physical exercise has been 
demonstrated numerous times in animals (Aldinger, 1970; Banister et al., 
1971; Bloor £t £l., 1970; Crews and Aldinger, 1967; Oscai £t al., 1971a; 
Penpargkul and Scheuer, 1970; Stevenson et al., 1964; Tipton and Tcheng, 
1971; and Tomanek e^ , 1972). 
The cellular morphological mechanism of exercise induced cardiac 
hypertrophy has not been completely determined. In exercise hyper­
trophy, the increased cardiac weight could be due to myocardial fiber 
hyperplasia, fiber hypertrophy or both. It is generally felt that 
myocardial fiber hyperplasia does not occur beyond the immediate post­
natal period. However, Shafig et al., (1968) reported myocardial 
fiber hyperplasia beyond that time. Crews and Aldinger (1967) reported 
that when the work load is increased to a greater extent by a pathologic 
mechanism, such as hypertension or aortic valvular disease, the increase 
in myocardial mass is the result of multiplication of myocardial fibers 
as well as an increase in fiber size. The exercise study of Tomanek 
et al., (1972), showing constant myocardial fiber diameter, favors 
hyperplasia and/or fiber lengthening as the cellular morphological 
mechanism of exercise cardiac hypertrophy. 
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The production of a resting bradycardia after sustained periods 
of vigorous exercise is a well established fact in man (Astrand, 1956; 
Cotton, 1932; Knehr et al., 1942; Steinhaus, 1933), as well as in 
animals (Clark, 1927; Marsland, 1968). Tipton (1965)reported heart 
rates for trained and nontrained rats of 312 and 336 beats/minute, re­
spectively; the animals were trained on a treadmill. In rats trained 
by forced swimming Lin and Horvath (1972) reported heart rates of 344 
and 382 beats/minute for trained and nontrained rats, respectively. 
The cause of the induced bradycardia has most frequently been 
claimed to be a neural cholinergic mechanism (Gollnick and Simmons, 
1967; Herrlich et al,, 1960; Raab et al., 1960). Although Schryver 
et^ £1^., (1969) indicated a sharp reduction in the level of sympathetic 
transmitter in the hearts of exercised-trained rats. 
Tipton and Taylor (1965) explained their results with rats by the 
hypothesis that trained populations have available more myocardial 
nonneural acetylcholine which supplements the action and the effect of 
the acetylcholine released at the vagal endings. This hypothesis is 
supported by the findings of Herrlich et al., (1960) which showed 
that trained rats have significantly more atrial acetylcholine than 
nontrained rats. 
In the recent study by Lin and Horvath (1972), however, it was 
concluded that training bradycardia resulted from greater reduction of 
sympathetic tone than of parasympathetic tone, although the activity 
of both sympathetic and parasympathetic systems was reduced in the 
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hearts of trained rats. 
The cardiac output and cardiac work were increased in isolated 
hearts from conditioned rats in the work by Penpargkul and Scheuer (1970). 
They also reported greater oxygen consumption and higher left ventricular 
pressures and dp/dt in conditioned hearts with atrial pacing, whereas, 
higher lactate and pyruvate concentrations occurred in sedentary hearts. 
Crews and Aldinger (1967) also presented evidence to support the 
concept that the exercise - hypertropied heart is functionally superior 
to the normal heart. In their study isometric systolic tension, left 
ventricular pressure, ventricular thickness, cardiac weight and cardiac 
volume were all increased in the exercised group as compared to the 
controls. 
In the case of exhaustive exercise however, Maher et al., (1972) 
reported that peak isometric tension and velocity of shortening were 
significantly reduced in left ventricular trabecular muscles from ex­
hausted rats. They concluded these findings indicate that exhaustion 
in the rat is associated with a depression in the intrinsic contractile 
state of the myocardium. 
The capillary number per fiber ratio in the rat heart was found 
to increase in response to exercise at all ages in the studies by 
Bloor al., (1970) and Leon and Bloor (1970). They also demonstrated 
that swimming exercise in rats resulted in an increased luminal cross-
sectional area of the main coronary arteries only in the rats tdiere 
cardiac hypertrophy occurred. Stevenson e^ , (1964) reported that 
the coronary tree size was found to increase in size as compared to 
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the cardiac weight, provided the exercise was not too strenuous. 
Mitochondrial degeneration due to exercise has been reported by 
Arcos ejt , (1968); Aldinger and Sohal (1970); Banister al., (1971); 
and King and Gollnick (1970). Arcos and his colleagues also found an 
increase in mitochondrial mass and number of mitochondria. The authors 
suggested that this increase in mitochondrial mass is a compensatory 
response to exercise and this increase brings about focal regions of 
hypoxia during overexercise which are responsible for degenerative 
changes. Aldinger and Sohal reported that digitoxin treated swimming 
rats had no degenerative changes in the mitochondria. In the study 
by Banister and his colleagues it was demonstrated that with physical 
training,exhaustive exercise has a less damaging effect on myo­
cardial mitochondria, suggesting that the heart adapts to exercise. 
King and Gollnick (1970) found that in rats exercised to exhaustion 
and sacrificed immediately afterwards that extensive swelling of the 
mitochondria occurred, with disruption and degeneration of the cristae. 
These changes were greater in a group exercised by running than in those 
exercised by swimming. However, 24 and two hours after running to 
exhaustion the ultrastructure of the left ventricular muscle was nearly 
normal, although after 2 hours the mitochondria were still moderately 
swollen. 
Evidence has been presented by Bamberger et al., (1969) that heart 
mitochondria from rabbits exercised to exhaustion showed a greater 
incorporation of 14c-leucine into mitochondrial protein than did heart 
mitochondria from nonexercised controls. This effect did not occur 
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in the liver nor was it due to hypoxia. 
In studies by Oscai £t a^., (1971b), they could not confirm an 
increase in mitochondrial protein or respiratory enzymes in the wyo-
cardium of exercised rats. They did confirm the interesting finding that 
exercise depresses the appetite of male rats, but not of female rats. 
The relationship between physical activity and thyroid function 
has been studied by several investigators (Bondy and Hagewood, 1952; 
Escobar Del Rey and Escobar, 1956a, 1956b; Rhodes, 1967; Volpe et al., 
1960; Wilson, 1966). 
Iirvine (1967, 1968) found that T^ turnover is increased with 
chronic physical activity and the protein bound iodine is decreased 
in both man and the horse. Story (1972) reported that chronic exercise 
by swimming in rats resulted in an increased thyroid hormone secretion 
rate (TSR). 
In humans Terjung and Tipton (1971) measured hematocrit and various 
thyroid parameters of the blood at timed intervals during exercise and 
for up to 24 hours after. No changes were found in plasma TSH concentra­
tions for any of the measurement periods. An increase in total con­
centration during exercise averaging 11 percent occurred, which was 
attributed partly to the hemoconcentration, however, the change in hemo-
concentration alone could not completely explain the elevated con­
centration. 
Winder and Heninger (1973) exercised rats for three weeks and 
reported that the plasma half-life of injected was 18 hours 
in the exercised animals as compared to 24 hours in sedentary controls. 
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The serum level was 0.011 ng/ml in controls and 0.015 ng/ml in 
exercising rats. No change was found in the in vitro deiodinating 
activity of liver, muscle or kidney homogenates in response to exercise. 
The authors concluded that the elevated degradation with exercise 
may be due to exposure of a greater proportion of the extrathyroidal 
T^ pool to degradative enzymes and not to increases in deiodinative 
enzymes in the peripheral tissues. 
Cardiovascular system in relation to age 
Although the basic mechanism involved in aging is quite unclear it 
is well known that with advancing age a significant reduction of 
physiological reserve often occurs in various organ systems (Shock, 
1962). 
Hruza (1972), in his review on aging, reported that in man the 
heart has the peculiar behavior of not changing in weight after about 
25 years of age, while almost all other organs decrease in weight with 
age. He also suggested that this may be due to atherosclerotic changes 
of the arteries overloading the heart and leading to functional hyper­
trophy. 
Lee et ad., (1972) reported that the ratio of left ventricular 
weight to body weight, and the estimated left ventricular volume to body 
weight were found to be significantly higher in old rats than in young. 
Thus, it appears that the hearts of old male rats not only show relative 
hypertrophy, but the left ventricular cavities are significantly larger. 
Other investigators have considered the importance of cardiac dilation 
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and hypertrophy and emphasized the associated undesirable characteris­
tics (Burton, 1957; Gorlin, 1962; Shipley £t al., 1937). These 
characteristics include: 1) a greater tension must be developed to 
produce a given pressure in a dilated ventricle according to the Law of 
Laplace (P = T/R); 2) the oxygen requirement and the oxygen diffusion 
distance are increased in the dilated heart; and 3) the coronary 
blood flow is increased relatively less than the mass of hypertrophy. 
Bloor e£ al^., (1970) exercised young (four weeks), adult (three -
four months) and old (over one year) male rats by swimming for ten 
weeks. In the young animals the ventricular weights of the exercised 
groups were significantly larger. In the adult group exercise pro­
duced no significant change in ventricular weights. In the old group 
the ventricular weight was significantly lower in the group exercised. 
The increased heart weight in the young exercised animals was reflected 
in increases in sarcoplasmic mass and in the number of myocardial fibers. 
The relative mass of myocardial capillaries also increased with exercise. 
In the old exercised rats the loss in heart weight reflected a de­
crease in sarcoplasmic mass. The relative mass of myocardial capil­
laries did not change. 
Tomanek et al., (1972) have also demonstrated the age - dependent 
hypertrophy response of the rat heart to exercise. In their study they 
found that aging is associated with an increase in hydroxyproline con­
tent of exercised hearts of old (22 months) rats, while the hyper­
trophy in young (6 month) rats due to exercise was not associated with 
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an increase in this collagen component. They also noted a general in­
crease in collagen with age in the heart without exercise. 
Florini e£ al., (1973) found the hearts in adult (8 months) and 
old (26 months) mice to ultimately exhibit the same percentage in­
creases in heart/body weight ratio to injections of thyroxine, with 
identical dose-response curves, but a significantly longer lag period 
occurred before hypertrophy in the older mice. Increase in the rate 
of protein synthesis, as measured by ^H-leucine incorporation into 
protein, was found to precede the increase in heart/body weight ratio 
in both age groups. However, the initial protein synthetic rate was 
lower in the older hearts. It was concluded by the authors that the 
lower protein synthetic rates in old hearts may signal an impairment in 
adaptability which may contribute to the increased incidence of heart 
failure with age. 
As early as 1880 von Anrep (1880) observed that resting heart 
rate decreased as age and body weight increased. More recent investiga­
tions have confirmed von Anrep'j findings (Lin and Horvath, 1972; 
Tipton and Taylor, 1965). In Sprague-Dawley rats under Nembutal 
anesthesia. Berg (1955) found that heart rate first increased and then 
decreased with aging (mean 353 beats/min. at 219 days of age, 376 
beats/min. at 557 days and 322 beats/min. at 851 days). A recent report 
by Barnard et al., (1974) also confirmed the findings in unrestrained 
Spraque-Dawley rats with values of 381 beats/min. in young (210g) and 
331 beats/min. in old (512g) rats. 
In the recent findings by Rothbaum et al., (1973) however, the 
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heart rate increased with age. In 12 and 24 month old Wistar rats the 
heart rates taken through implanted intra-arterial catheters in un-
anesthetized animals were 314 and 331 beats/min., respectively. In 
Rothbaum's study beta-adrenergic blockade abolished the significant 
difference in heart rate. Therefore, a greater resting sympathetic 
tone in the older rat may have accounted for the age difference in 
the resting heart rate. This increased sympathetic tone may have been 
either a compensatory response to a lower resting cardiac output or a 
reflection of greater anxiety in the old than in young animals. 
Numerous studies have been reported on the effects of aging in 
man on the cardiovascular dynamics. Brandfonbrener et al., (1955) 
found a decrease in the resting cardiac output with age. 
However, because coronary artery disease also increases with age 
in man it is difficult to separate the age changes from the disease 
changes. Since the rat is virtually free of large vessel coronary 
atherosclerosis and heart disease (Rothbaum et al», 1973), it is 
a useful animal in which to investigate age changes on the cardivascular 
parameters. 
Rothbaum et al., (1973) found significantly lower cardiac index 
and stroke index values in old (24 months) compared to young (12 
months) rats, as well as slightly lower blood pressures in the old 
compared to the young rats. Because the cardiac index and stroke index 
remained significantly lower in the old than in the young rats it was 
not felt that the decline in these two parameters with age was related 
to differences in the sympathetic nervous system tone. 
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Other researchers, however, have found slightly higher blood 
pressures in old rats as compared to young rats (Berg and Harmison 
1955; Friedman et a^., 1958). Lee et a^., (1972) found mean blood 
pressures of 91, 93 and 104 nmHg in young (6 months), adult (12 months) 
and old (24 months) rats, respectively. 
Mean aortic blood flow was also measured in the study by Lee 
et al., (1972) with an electromagnetic flowmeter probe around the aorta 
near the heart. The mean aortic flow of the 24 month-old rats (83.4 
ml/min/kg) was only slightly lower than that of 6- and 12- month old 
rats (90.2 and 90.8 ml/min./kg, respectively). This difference, was 
much less than that attributable to age in human studies (Brandfonbrener 
e£ ail., 1955; Landowne et al., 1955; Lewis, 1938), or in the isolated 
rat heart or heart-lung preparations (Shreiner et al., 1967; Shreiner 
et al., 1969; Solomon et , 1965). When the cardiac performance was 
tested during increased afterloading produced by infusions of angio­
tensin II, however, the end diastolic pressure increased much more 
in the old than in the young animal. Thus, the older hearts were less 
able to deal with the increased pressure load. 
Changes in the physiology of the vascular system with age have 
focused on two problems: 1) the effects of reduced elasticity, and 
2) the altered distributions of flow. 
1) A decrease in the elasticity of old arteries was demonstrated 
by Roach and Burton (1959) when they showed that half of the collagen 
is at maximal length with 60 percent stretch in young arteries, whereas 
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in old arteries the same level is reached with 30 percent stretch. 
The pulse wave velocity depends on the diastolic pressure and 
the elasticity of the blood vessel. It has been found to correlate 
with age (Harrison et £l., 1964; Nielsen e^ £l., 1968). Hallock (1934) 
found an increase in the aortic pulse wave velocity from 4.1 to 10.5 
meters/sec. at 5 and 65 years of age, respectively. This increase in 
pulse wave velocity appears to be independent of atherosclerosis. 
2) The redistribution of blood flow with age was presented in a 
review by Bender (1965). The flow to the heart and the brain were 
found to be reduced less than the total cardiac output, which declined 
on the average of about 1.01 percent/year in man. The flow to the 
kidneys and liver were shown to decrease more than the cardiac output. 
The peripheral" resistance has been found to increase with age, out 
of proportion to the changes in cardiac output or residual metabolic 
activity (Landowne ejC , 1955). 
Several researchers feel that the changes in the cardiovascular 
dynamics are pathological in nature and a problem of atherosclerosis. 
However, as pointed out by Landowne and Stanley (1960) the loss of 
elasticity of the aorta and major vessels is enchanced by the 
atheroscleratic process, yet these vessels become rigid even in the 
absence of atherosclerosis. 
Several features of old age, such as low metabolic rate, in­
tolerance to cold, dryness of skin, sparseness of hair, hypercholes-
terolaemia and increased atherosclerosis are also commonly found with 
hypothyroidism (Lorand, 1904; Korenchevsky, 1961; Pittman, 1962). 
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Consequently it has been suggested that aging is caused by the failure 
of the thyroid gland to secrete sufficient thyroxine to maintain the 
youthful level of body function (Lorand, 1904). However, in relation 
to thyroid hormone and life duration Everitt (1959) found a reduced 
life duration in rats treated with thyroxine and Tsuji and Ogura (1969) 
found that mild hypothyroidism increased life expectancy in man. 
With age morphological studies suggest an involution of the 
thyroid gland. There is a decrease in the height of the thyroid 
epithelium, the follicles become atrophic and increasing amounts of 
connective tissue accumulate in the thyroid gland with age (Stoffer e^ 
al., 1961; Korenchevsky, 1961; Mustacchi, 1950). 
Measurements of serum protein bound iodine show little or no 
change with age (Gaffney et al., 1960; Wilansky e^ , 1957). The 
thyroid secretion rate, however, has been shown to decrease with age, 
both in man (Gregerman ^  a^., 1962) and in the rat (Grad and Hoffman, 
1955; Wilansky £t a^., 1957; Kumareson and Turner, 1967; Narang and 
Turner, 1966; Turner, 1969; Story, 1972). In a recent report by 
Rubenstein et al^., (1973) in humans aged 5 to 93 there was a statistical­
ly significant, progressive decrease in Tg concentration with advancing 
age, however, they showed no decrease in total T^. 
Cholesterol Metabolism 
The following gives a brief history of cholesterol as derived from 
more comprehensive reviews by Cook (1958), Kritchevsky (1958), Dietschy 
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and Wilson (1968) and Bortz (1973). Other advancements that have been 
made in cholesterol investigation, which apply to the present study, 
will be presented in the following review. 
1733 Vallisnieri and 
1775 Conradi 
1815 Cheverul 
1859 Berthelot 
1868 Wislecenus and 
Moldenhauer 
recognized and observed 
various properties of a 
substance which was later 
to be called cholesterol 
in gallstones. 
gave the substance the name 
cholesterine (Greek: chole, 
bile, and stereos, solid). 
showed that an esterifiable 
hydroxyl group was present. 
indicated -existence of a 
double bond. 
1888 Reinitzer 
1919 Windaus and Wieland 
determined the exact 
empirical fozmila 
(G27 5^ 6°)' 
determined a tentative 
structural formula. 
1932 Wieland, Dane, 
Rosenheim and King 
1%3 Schoenhaimer and 
Breusch 
1937 Rittenberg and 
Schoenheimer 
1942 Block and 
Rittenberg 
determined correct structural 
formula, cyclopentanoper-
hydrophenanthrene. 
elucidated central features 
of cholesteral metabolism 
in intact animals. 
gave first concrete proof 
of cholesterol synthesis. 
demonstrated the incorpora­
tion of deutero-acetate into 
cholesterol in vivo. 
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Bûcher 1953 detailed the synthesis of 
cholesterol by cell-free 
homogenate preparations 
of liver. 
In large part due to the belief that cholesterol abnormalities in 
man are possibily killing him, and in part because it is so intriguing, 
a vast amount of information has been published on the subject of 
cholesterol. It is certainly beyond the scope of this review to 
categorize all of these reports. Instead, a brief outline will be 
given on cholesterol general metabolism, centering mainly on its 
regulation, and finally an individual look will be taken at the effects 
of thyroid hormone, exercise and age on cholesterol metabolism. 
General cholesterol metabolism 
The work of many scientists, including the Nobel award efforts of 
Block (1946) and Lynen (1955), have detailed the biochemical steps 
required for the formation of cholesterol. 
18 acetyl CoA > cholesterol + 9002-
A more con^lete scheme showing some of the approximately 26 steps 
involved in cholesterol formation is shown in Figure 1. Additional 
information about the discovery of the individual steps of cholesterol 
synthesis can be obtained from Kritchevsky (1958) and Popjak and 
Comforth (1960). 
Since the first studies by Block et al. 1946, where 
it was demonstrated that labeled acetate was incorporated 
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Figure 1. Diagrammatic representation of major steps in cholesterol 
metabolism 
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into digitonin preclpitable sterols in liver slices, but not in slices 
of other organs, it has become apparent that every mammalian tissue is 
capable of at least some ^  novo cholesterol synthesis (Srere £t al., 
1950; Popjak and Beechmans, 1950). 
Looking at cholesterol synthesis in the rat (Dietschy and Siperstein, 
1967) and in the squirrel monkey (Dietschy and Wilson, 1968) it was 
found that the highest rates of sterol synthesis occurred in the liver 
and small intestine. The rate of synthesis appeared to occur about 2 
and 6 times higher in the liver than in the most active portion of the 
small intestine, the ileum, in the rat and the monkey respectively. 
Data on humans is not conclusive, but it appears that the rate of 
synthesis is about equal in both tissues (Dietschy and Wilson, 1970), 
in contrast to the rat or monkey. However, it appears likely that the 
liver is of at least as great a quantitative importance due to mans 
relative inability to absorb dietary cholesterol (Wilson et al., 1967; 
Bhattathiry and Siperstein, 1963). 
The first few steps involved in cholesterol synthesis are also 
part of pathways common to other metabolic end products like CO2, fatty 
acids and ketone bodies. The fourth step however, involving the re­
duction of beta -hydros-beta -me thy 1 glutaryl CoÂ (HMG-CoA) to mevalonic 
acid by the enzyme HMG-CoA reductase is an irreversible reaction that 
leads nearly exclusively to cholesterol. This step in the metabolic 
synthesis of cholesterol has been found to be the major rate limiting 
step, with HMG-CoA the rate limiting enyzme. 
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Taylor and Gould (1950) were the first to show a prompt and marked 
suppression of cholesterol synthesis due to cholesterol feeding in 
liver slices. The gastrointestinal tract did not show this decrease 
in synthesis (Dietschy and Wilson, 1970). Although the data is not 
conclusive it appears that in man similar effects of cholesterol 
feeding are seen. In two other tissues decreased synthesis with 
cholesterol feeding occurred, in the bone-marrow cells (Takeuchi et al., 
1966) and in mouse lymphoblasts and fibroblasts (Bailey, 1967). These 
are not quantitatively important in overall sterol balance, however. 
It was this property of feedback inhibition by cholesterol which 
led to the determination of the HMG-CoA to mevalonic acid step as 
the rate limiting step in cholesterol synthesis (Gould and Popjak, 1957; 
Bucher et al., 1959; Siperstein and Guest, 1960; Siperstein and Pagan, 
1966). 
It has also been shown by Gould and Swyryd (1966) that more chronic 
feeding of cholesterol leads to depression of the later steps (mevalonate 
to farnesyl pyrophosphate and farnesyl pyrophosphate to squalene) of 
cholesterol synthesis. 
It has been observed by Siperstein and Pagan (1966)that this 
control mechanism for cholesterol synthesis is lost when liver cells 
became malignant. In a recent study by Brown et al., (1973), identical 
properties for solubilized and highly purified HMG-CoA reductase from 
normal liver and hepatoma tissue was reported. This observation and 
other data reviewed in their paper led them to suggest that in normal 
liver the activity of HMG-CoA reductase is controlled by alterations 
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in synthesis and degradation of the enzyme, rather than by direct 
allosteric effects on the enzyme. 
Utilizing another system involving cultured human fibroblasts 
Brown £t al., (1974) has shown that HMG-CoA reductase is suppressed in 
a medium containing whole serum. The low density and very low density 
lipoproteins were found to be where the responsible factor is located, 
while it was not found in high density lipoproteins. Cholesterol 
itself was also able to cause suppression of the HMG-CoA reductase 
when added in a nonlipoprotein form. It was suggested that low density 
and very low density lipoproteins reduce enzyme activity by delivering 
cholesterol to the cell. The cholesterol, in turn, acts to inhibit the 
synthesis of new HMG-CoA reductase. 
Not all work has supported the idea of cholesterol as a true end 
product "feedback" inhibitor of its own formation, however. Bortz 
(1973), in his short review of cholesterol synthesis control, cited the 
following factors against the cholesterol inhibitor theory: 
1) some cholesterol preparations, like emulsions, suspensions and 
lipoprotein complexes were not inhibitory to cholesterol 
synthesizing homogenates or partially purified enzyme 
preparations, 
2) there was no loss of synthetic ability in cell fractions 
combined from control and cholesterol fed animals, indicating 
the lack of a soluble inhibitor in the cholesterol fed 
animal, 
3) a reciprocity between cholesterol-forming capacity and 
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hepatic cholesterol content have been shown in various ex­
periments and 
4) the lack of sensitivity of tumors to dietary regulation was 
not due to a deletion effect, but from the failure of the 
substances to penetrate the tumor tissue. 
The effect of bile, particularly bile acids, have been proposed 
by some to be the agents of control of cholesterolgenesis. Bile acid 
feeding was shown by Beher and Baker (1958) to decrease cholesterol 
formation from acetate. It has also been shown that a bile fistula 
(Econumu et al., 1958; Myant and Eder, 1961), ileal bypass (Moutafis 
and Myant, 1968) or administration of cholestyramine, as in the rat 
(Huff et al., 1963), have resulted in a marked increase in cholesterol 
formation. 
There are also indications that bile may not be the direct 
feedback inhibitor. Siperstein (1960) found that pure bile acids do not 
inhibit cholesterolgenesis in liver slices vitro. It was suggested 
in Dietschy and Wilson's review (1970) that contamination may have 
caused the inhibitory effects. 
In response to these findings a scheme was proposed by Weis and 
Dietschy (1969) in which hepatic cholesterol synthesis is controlled by 
cholesterol reaching the liver from the intestine in chylomicrons. 
Since bile acid is required in this transport process the effects seen 
by bile are explained by this scheme, with no direct effect of bile. 
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Experimental data in support of this model is given by Dietschy and 
Wilson (1970). They also noted that since cholesterol synthesis in 
the intestine is not inhibited by cholesterol, while bile acid does 
inhibit it, that in contrast to the liver the intestine may be under 
direct control of bile acid. 
It was demonstrated by Tomkins and Chaikoff (1952) that fasting 
resulted in a decrease in cholesterol synthesis by the liver. Bucher 
££ ±1-, (1960) found a reduction in HMG-CoA reductase with fasting, 
which appeared to be confined to the liver. It appeared that with 
fasting, at least, no inhibitor or inducer was involved, but there was 
a diminution in the amount of HMG-CoA reductase. 
A diurnal fluctuation in the rate of cholesterol synthesis in the 
rat and mouse was found by Bach et al^., (1969) ; Horton £t al., (1970) 
and Edwards et al^., (1972), where the maximum in synthesis occurs 
around midnight and the minimum is around 10 A.M.. This rhythm was found 
to follow the feeding schedule of the rats, however, it persisted in 
the fasted rat (Shapiro and Rodwell, 1972). 
Subsequent findings that the fluctuation in synthesis is due to 
changes in HMG-CoA reductase, and that puromycin and cychoheximide 
blocked the rise in synthesis led Bortz (1973) to conclude that the 
rate of synthesis of HMG-CoA reductase, and not changes in its activity 
by feedback inhibitors, results in changes in cholesterol formation. 
Diurnal oscillations have also been noted for bile acid synthesis 
(Danielsson, 1972), which coincides with that of cholesterol formation; 
and in hepatic fatty acid synthesis (Kimura et al., 1970; Bortz and 
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Steele, 1973), which varies inversely with cholesterol synthesis. 
Because of other situations where hepatic cholesterol synthesis 
increase shares a common feature of increased fat flow to the liver, 
and the time pattern seen with the diurnal changes in the rat, 
Bortz (1973) proposed that fat flow to the liver may be the inducer of 
the formation of HMG-CoA reductase. 
In concluding cholesterol synthesis, the factors influencing 
hepatic cholesterol synthesis in the rat, as presented by Bortz (1973) 
are shown in the following table. 
Table 1. Factors influencing hepatic cholesterol synthesis in the rat. 
(as presented by Bortz, 1973) 
Increase Decrease 
Bile duct fistula 
Ileal bypass 
Cholestyramine 
Bile duct obstruction 
Refeeding 
Fat feeding 
Youth 
Female 
Hyperthyroid 
Growth hormone 
ACTH 
DOCA 
Cortisone 
Nor-adrenal 
Adrenalin 
Diabetes 
Glucagon 
Tiriton 
X ray 
Stress 
Nephrosis 
Cholesterol feeding 
Bile acid feeding 
Fasting 
Low fat feeding 
Age 
Male 
Hypothyroid 
Hypophysectomy 
Adrenalectomy 
Nicotinic acid 
Clofibrate 
Estrogen 
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The mechanism of cholesterol absorption has been briefly reviewed 
by Dietschy and Wilson (1970). The mixture of free and esterified 
cholesterol found in the intestinal lumen is of exogenous and endo­
genous origin. The cholesterol esters are hydrolzyed to mixed micelles 
and moves through the brush border of the intestinal cell in this form, 
probably by passive diffusion. In the intestinal mucosal cell 
cholesterol mixes with other cholesterol forms, like that derived by 
synthesis in the intestinal" cell from acetate. Some of the cholesterol 
is also esterfied with long-chain fatty acids. These forms of 
cholesterol are then released as chylomicrons into the intestional 
lymph. 
It has been found that a high fat diet increases exogenous 
cholesterol absorption (Kim and Ivy, 1952), and that bile acids are 
needed for cholesterol absorption (Siperstein jet £1-, 1952). Of the 
steps outlined above in cholesterol absorption, the last step, in­
volving movement into the lymph, has been found by Sylven and Borgstrom 
(1968) to determine the overall rate of cholesterol absorption and pos­
sibly a point where bile acids are involved. 
Large differences in cholesterol absorption between species have 
been reported, especially differences between man and other animals. 
Dietschy and Wilson (1970) reviewed this subject in nine different 
publications and found that where man absorbs less than 10 percent of 
the cholesterol fed, other species (dog, rat and rabbit) absorbed from 
30 to 70 percent of the cholesterol fed. The reasons for the differences 
are obscure. 
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Cholesterol may be metabolized to bile acids, sex hormones or 
adrenocortical hormones. Of these the major one has been found to be 
bile acids (Kritchevsky, 1960). The cholesterol excreted by the bile 
direct is about 8 percent sterol and 92 percent as bile acids (Bortz, 
1974). 
The conversion of cholesterol to bile acids was recognized as one 
of the major excretory routes of cholesterol after the work of Siperstein 
etal., (1952). 
The control of bile acid production has been proposed to be due 
to two feedback mechanisms: 1) the bile acid-bile acid feedback and 
2) the cholesterol-bile acid feedback. 
1) Evidence for the first mechanism includes an increase in bile 
acid secretion after bile duct canulation, administration of the bile 
acid-binding resin, cholestyramine, and ileectomy; while a decrease 
occurs with administration of bile acids. Evidence has also been 
presented, however, that the increase in bile acid production may be 
under the control of cholesterol reaching the liver (Dietschy and Wilson, 
1970). 
2) The increase in bile acid formation by cholesterol was first 
shown by Abell £t a^., (1956). The importance of this mechanism is 
shown when thiouracil is fed to inhibit the increase in bile acid pro­
duction induced by cholesterol in the rat and extreme hypercholesterolemia 
results (Wilson, 1962). In the rabbit this compensatory mechanism was 
not found (Hellstrom, 1965), and cholesterol feeding results in 
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hypercholesterolemia. 
Several researchers have shown an increase in the excretion of 
cholesterol as neutral or acidic products by unsaturated fatty acids 
(Bortz, 1974; Nestel, 1970). This effect may be caused by the formation 
of more polar, water-soluble, ester substrates, by changing the steric 
configuration of cholesterol or to a redistribution of cholesterol in 
the body (Spritz and Mishkel, 1969). 
Cholesterol and bile acid turnover have been found to be acceler­
ated (Nestel, 1970; Kottke, 1969) with elevation of blood triglyceride 
levels (type IV hyperlipoproteinemia). It has been proposed that these 
features are expected under increased fat and calorie flow. 
Conversely, familial .hypercholesterolemia type II hyperlipopro­
teinemia) shows low levels of cholesterol synthesis and turnover, and 
it seems likely that familial hypercholesterolemia is caused by some 
defect in the output mechanism of cholesterol (Bortz, 1974). However, 
Brown and Goldstein (1974), using cultured cells from homozygotes with 
familial hypercholesterolemia found a deficit in this cell surface 
receptor for low density lypoproteins (LDL). Consequently, LDL failed 
to suppress the HMG-CoA reductase activity and cholesterol is over­
produced . 
Cholesterol metabolism in relation to thyroxine 
Several investigators have shown an increase in serum cholesterol 
levels in hypothyroidism and, conversely, a lowering of serum cholesterol 
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levels in hyperthyroidism or treatment with thyroid hormones (Boyd and 
Oliver, 1960; Feuer, 1963; Jones e^ , 1959; Strisower et ai., 1957; 
Strisower et al., 1968). The subject has been reviewed by Kritchevsky 
(1960) and Myant (1964). 
The cholesterol concentration with thyroid deficiency in humans-
may increase from less than 280 mg percent of plasma to over 700 mg 
percent (Myant, 1964). In rabbits no rise (Turner and Khayat, 1933), 
or only a slight rise (Fleishmann al., 1940), has been reported 
with thyroid deficiency. In contrast, studies by Lee et ai., (1970) 
and Liu and Lee (1972) showed a decrease in plasma cholesterol con­
centration in the guinea pig when treated with 131j and an increase in 
the concentration of total cholesterol with a single injection of T^. 
The influence of diet on the blood cholesterol levels in thyroid 
deficiency is discussed in Myant*s review (1964). On a normal diet 
the blood cholesterol level fluctuates and remains high in the thyroid-
deficient dog, however, with starvation the cholesterol levels fall; 
or with cholesterol added the blood cholesterol level rises, with 
cholesterol being deposited in the walls of the arteries. In order 
to produce marked retention of cholesterol with cholesterol feeding in 
the rat, however, it has been found necessary to add cholic acid as well. 
In the past suggestions have been made to explain the changes in 
cholesterol concentration occurring with thyroid changes: 1) re­
distribution of the body cholesterol between the plasma and tissues 
could occur, 2) the absorption efficiency of dietary cholesterol could 
change. 3) or changes in synthesis, excretion or conversion to other 
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substances could occur. The first two of these are generally no longer 
accepted (Myant, 1964). 
That the thyroid hormones do affect cholesterol synthesis was 
discussed in Kritchevsky's review (1960). Karp and Stetten (1949) 
and Byers et al^., (1952) found that in the intact rat the rates of 
cholesterol synthesis and turnover were lower in the hypothyroid and 
higher in hyperthyroid rats as compared to normal animals. Using liver 
slices, Fletcher and Myant (1958) found an 82 percent decrease in the 
biosynthesis of cholesterol from acetate in thyroidectomized rats, 
while thyroxine injection caused a 2-3 fold increase in synthesis rate. 
There was no effect on the rate of biosynthesis from mevalonic acid. 
In experiments conducted by Gudner et-a^., (1968) the activity of 
HMG-CoA reductase fell markedly in thyroidectomized rats, while in hypo­
thyroid rats, given a single dose of 50 mico-grams of T^, the HMG-CoA 
reductase level remained low until 30 hours after injection, at which 
time a rapid increase in the enzyme activity occurred. The data sug­
gests the action of thyroid hormone is on the elevated synthesis of 
new HMG-CoA reductase and not on the direct action of the hormone on 
the enzyme. 
These findings that thyroxine stimulates cholesterol synthesis 
in the liver clearly does not explain the changes in plasma cholesterol 
levels with thyroid alterations, however, since the changes are in the 
opposite direction. 
In a series of papers published in 1952 by the Rosenman, Friedman 
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and Byers* group (Byers et al., 1952; Friedman _et al.1952; Rosenman 
et al., 1952a; Rosenman et^ ajL•, 1952b) the effect of the thyroid gland 
on degradation and excretion of cholesterol was studied. They found 
that the hypercholesterolemia of the hypothyrôid rat occurred despite 
any impaired rate of cholesterol synthesis and that rates of both ex­
cretion and catabolism of cholesterol were impaired in the hypothyroid 
rat. Eriksson (1957) found a diminished biliary excretion of cholic 
acid, but an increased excretion of chenodeoxycholic acid in the hyper-
thyroid rat. In a recent paper by Byers and Friedman (1973) it was con­
cluded that it is probably the relative failure of the thyroidectomized 
rat to convert cholesterol into bile acids that is chiefly responsible 
for the hypercholesterolemia. 
Utilizing the two-pool cholesterol method of Goodman and Noble 
(1968), Lehner et al., (1972) studied the effects of hypothyroidism 
on cholesterol metabolism in the squirrel monkey. The two-pool method 
involving specific activity-time curves of serum cholesterol as used 
is dicussed under MATERIALS AND METHODS of this paper. The hypothyroid 
monkeys had higher serum cholesterol levels than controls; a markedly 
smaller metabolic turnover rate (PR^); a lower intake of dietary 
cholesterol, although the percentage absorbed was the same; an almost 
doubled mass of pool B, the slow turnover cholesterol pool; and a smaller 
percentage of pool A, the rapid turnover cholesterol pool, excreted 
per day as reflected by a smaller rate constant of excretion, kg. 
The effects of D-thyroxine on patients with familial hyperbeta-
lipoproteinaemia was recently reported by Simons and Myant (1974). 
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The following sequence of events was presented. The immediate response 
to D-thyroxine was a rapid increase in clearance rate of cholesterol, 
leading to decreased plasma concentration since synthesis of cholesterol 
did not increase as rapidly. This led to a decrease in removal, re­
flected by a secondary fall in fecal excretion of endogenous steroids. 
Therefore, with continued D-thyroxine treatment the patient can main­
tain a normal rate of removal of cholesterol from the body in the 
presence of a reduced pool of exchangeable cholesterol. It was further 
suggested by Simons and Myant that cholesterol from the tissues, as 
well as plasma cholesterol, contributed to the increased fecal ex­
cretion of endogenous steroids. Because in two patients in the study 
neutral steroids excretion was stimulated and in one the main effect 
was on bile acid excretion it was suggested that D-thyroxine acts at 
some step before divergence of the two pathways. For exançle, D-
thyroxine might in some way facilitate the entry of plasma cholesterol 
into liver cells. 
Another suggestion presented by Schweppe and Jungmann (1969) is 
that since thyroxine increases the formation of cholesterol esters, 
the increase in esterification may play a role in the mechanism by which 
thyroxine reduces plasma cholesterol levels. 
Evidence has also been presented by Byers e£ a^., (1970) that 
growth hormone is necessary for the cholesterol lowering effects of 
thyroxine. They theorized that since growth hormone levels are re­
duced in the thyroidectomized animal the resulting hypercholesteremia 
of hypothyroidism was due to the lack of growth hormone. 
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As a final note, since much of the work involving cholesterol 
alterations has an ultimate purpose of a better understanding of athero­
sclerosis, it has been reported by Fu et , (1973) that the re­
lationship between thyroid hormones and atherosclerosis may not be 
linked through changes in serum cholesterol levels, but through 
alteration of the aortic mucopolysacharides. 
Cholesterol metabolism in relation to exercise 
The effects of exercise on serum cholesterol levels and other 
lipid factors has been looked at exhaustively over the years. However, 
because of differences in exercise methods and duration, species dif­
ferences, age, diet, mental and unknown factors, the specific effect of 
exercise has been difficult to determine. Consequently, little is 
actually known about the mechanism of action of the effect of exercise 
on cholesterol. 
Numerous epidemiological studies have been conducted which in­
dicate a possible relationship between physical exercise and serum 
cholesterol levels. These studies usually compared findings between 
people of different racial or ethnic backgrounds (Mann et al.. 1964; 
Merskey et al., 1960; Sharper, 1962) or between work patterns within a 
group (Calvy et al., 1963; Gsell and Mayer, 1962; Melichar, 1965). 
Several epidemiological studies have likewise found no or little 
correlation between exercise and serum cholesterol levels (Keys et al., 
1958; Malhotra, 1967; Taylor et al., 1967). 
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In human experimental studies both a lowering of serum cholesterol 
level (Naughton and Balke, 1964; Mann et al., 1955) and no change in 
serum cholesterol level (Holloszy et al., 1964) due to exercise have 
been reported. Several investigators, however, have pointed out that 
consistent and vigorous exercise is needed for the cholesterol lowering 
effect to be apparent (Campbell, 1965; Golding, 1961). 
Concerning the mechanism of the cholesterol lowering effect of 
exercise in man, Malinow and Perley (1969) suggest that an increase in 
cholesterol oxidation occurs during physical activity, as reflected by 
increased excretion of labeled CO2 after injection with radioactive 
cholesterol. 
As in human studies there have been reports of no change in serum 
cholesterol with exercise in animal studies by Paris £t £l., (1971); 
Hanson et £i., (1967); Hughes e£ £l., (1971); Lewis et al., (1961) and 
Link et al., (1972). However, it has been shown that other factors may 
be related to these findings. 
The duration and vigorousness of the exercise have been suggested 
as factors by Gollnick and Simmons (1967) and Papadopoulos £t a_l., 
(1969). In the first study a decrease in plasma cholesterol occurred 
only in animals exercised by swimming for 60 minutes/day, and not in 
those exercised 15 or 30 min/day. In a recent study by Monsen et^ a^., 
(1972), however, voluntary exercise, in which rats voluntarily ran over 
2 miles/day, produced a lowering of plasma cholesterol which was sig­
nificant after eight weeks. It was suggested that the stress of imposed 
exercise may be complicating the effects seen in other exercise studies. 
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Diet has also been found to affect the cholesterol lowering re­
sponse to exercise. A decrease in serum cholesterol was found in 
rabbits (Brown et £l., 1956) when the animals received a high 
cholesterol diet and in rats (Lewis et al., 1961) a decrease was found 
only on a high fat diet. Montoye et ^.,(1962), however, found a de­
crease in cholesterol with exercise in rats regardless of what the diet 
consisted. 
The effects of age on the cholesterol lowering response to ex­
ercise also appears to be evident. Jones £l., (1964) and Montoye 
et £l. , (1962) found that although exercise did not significantly lower 
serum cholesterol it did prevent the increase of serum cholesterol 
associated with old age. 
A study involving training and detraining in rats was conducted 
by Watt et al. (1972) in which training lowered serum cholesterol, 
serum triglyceride and adipose triglyceride levels, but had no effect on 
those lipids in heart or skeletal muscle. A retention of lowered blood 
cholesterol by the detrained rats was suggested as resulting from di­
version of acetylcoenzyme A from cholesterol to fat synthesis due to 
the lowered body fat after training. 
Gollnick and Simmons (1967) found that exercised animals ex­
creted more sterol in the feces and Hebbelinck and Casier (1966) re­
ported that exercise stimulated the conversion of cholesterol to bile 
acid and increased the rate of excretion via the feces in mice. 
Simko (1970) suggested that the increased incorporation of acetate 
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into liver cholesterol in exercising rats is secondary to the lowering 
of liver cholesterol, which may be affected by unsaturated fatty acid 
released from depot fat during exercise. 
Cholesterol metabolism in relation to age 
The general increase with age of various lipids in man has been 
demonstrated by several investigators (Brody and Carlson, 1962; 
Carlson, 1960). Darmady et al., (1972) found blood cholesterol values 
in man to increase from 80 to 150 to 191 mg percent in cord blood, at 
one week and at one year of age, respectively. It was demonstrated by 
Keys e^ £l. (1950) that serum cholesterol levels in man rise at the 
rate of 2.2 mg per year between the ages of 17 and 30. 
In a study by Werner et al. (197&) the mean cholesterol levels 
appeared to reach a plateau at 50-59 years of age in men, whereas in 
women there was a sharp rise in cholesterol levels after age 50 and a 
plateau reached later. There was an increase in mean cholesterol level 
(mg/100 ml) from the ages of 0-12 and 60-69 years, of 194 to 259 and 197 
to 285 in men and women, respectively. 
In a review by Bierman (1973), in men and women, there was a 
gradual increase in triglyceride levels until a peak was reached at 
40 to 45 or 50 to 60 years of age, respectively, after which there was 
a decline in both. The same pattern appeared to occur for cholesterol 
with a peak reached in men between the ages of 40 and 50 years and in 
women between the ages of 50 and 60 years. For both plasma triglycerides 
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and cholesterol levels the curves followed a similar pattern as for 
relative body weight. It was noted in the review that the decline in 
all curves in later age may be reflected by deaths in individuals 
with high levels of these parameters at an earlier age. However, the 
question was raised of whether such age-associated changes are all a 
reflection of adiposity. The study by Nestel et a_l. (1969), in which 
a close relationship between cholesterol production rates and excess 
body weights was observed, lends support to this hypothesis. In his 
review Bierman (1973) concluded by suggesting that current concepts 
of plasma lipoprotein transport imply that the accumulation of cholesterol 
in the circulation is secondary in part to excessive production of 
triglycerides. 
In the aging rat Carlson e^ a^. (1968) found an increase in plasma 
triglycerides, cholesterol and phospholipids with age. The cholesterol 
levels were 94, 98, 218 and 307 mg/100 ml. at 1, 4, 9, and 18 months of 
age, respectively. The plasma free fatty acids did not change. Changes 
also were not found in either the heart or liver lipids, suggesting an 
inability to clear circulating lipids rather than deposition. These 
studies were done on Sprague-Dawley rats. 
In male rats of the Sprague-Dawley-RoIfsmeyer strain Story (1972) 
found mean values of 50.2 and 65.3 mg/100 ml of serum cholesterol in 
140 and 270 day old rats, respectively. Naito (1971) found a mean 
value of 57.8 mg/100 ml of serum cholesterol in 140 day old rats of the 
same strain. 
It was pointed out in a review by Kritchevsky (1972) that the strain 
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of animal needs to be considered. In the BN and Lewis rat strains 
cholesterol levels fall at 90 days, while they are unchanged in the 
DA strain- In the Wistar rat Yamamoto and Yamamura (1971) found values 
of 71.3, 67.5 and 76.6 mg/100 ml. for serum cholesterol at 2.4 and 18 
months of age. 
Although Yamamoto and Yamamura (1971) found no significant change 
in serum cholesterol levels with age in the Wistar rat, they did find 
decreased synthesis of cholesterol, as reflected by ^  vitro and in vivo 
studies. These studies substantiate earlier work by Block e^ al•, (1946) 
with liver slices; by Srere et al. (1950) with skin, and by Trout et al. 
(1962), who found that synthesis of cholesterol in slices of rat skin, 
aorta, tendon and liver was decreased in tissues from old rats (15 
months to three years compared to young rats four weeks or less). 
Yamamoto and Yamamura (1971) also found a decrease in gastrointes­
tinal absorption of cholesterol with age, as well as a decrease in 
biliary and fecal excretion of cholesterol and its metabolites. In an 
earlier study Rosenman and Shibata (1952) also showed a decrease in bili­
ary output of cholesterol of almost 50 percent between 6 and 44 weeks 
of age in the rat. 
In a recent investigation by Dupont _et (1972), however, no re­
duction of cholesterol synthesis from acetate between three and 18 
months of age in rats was noticed, nor was there a decrease in the ex­
cretion of cholesterol between six and 18 months of age. Age was found 
to be the major factor affecting the large carcass acidic steroid levels 
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in older rats in their study. A slower turnover rate in the older 
rat was suggested, if one assumes that steps in cholesterol turnover 
involves neutral cholesterol to acidic steriod to fecal steroids. 
In a series of papers by Hruza and colleagues (Hruza, 1971a; 
Hruzg, 1971b; Hruza et a^., 1973; Hruza and Wachtlova, 1969; Hruza and 
Zbuzkova, 1973) the cholesterol turnover in old rats was decreased from 
that in young rats. This was found to be partly due to a slower ex­
change of blood and tissue cholesterol and by slower excretion of 
cholesterol from the body of the older animals. There was a more pro­
nounced decrease in the excretion of cholesterol in the steroid fraction 
than in the bile acid fraction. Because the differences in excretion 
of cholesterol between young and old animals remain the same after 
ligation of the common bile duct, the decrease with aging must occur 
both in the bile and the intestinal secretion. 
Hruza £t a^., (1973) reported that hypophysectomy or thyroidectomy 
decreased excretion in the feces or exchange of cholesterol between 
blood and tissues in rats up to three months of age, but is not effective 
in rats one year old. It was also found that treatment with thyroxine 
or growth hormone in old rats increased the excretion of cholesterol 
a small amount, but that exchange of blood and tissue cholesterol was 
not affected in the older rat. It was concluded that a smaller 
sensitivity of hormones affecting cholesterol metabolism in old animals 
may be partly responsible for the decreased'turnover of cholesterol with 
aging. 
Hruza (1971a) and Hruza and Zbuzkova (1973) did find that by 
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parabiotic connection of young with old rats there was an increase in 
the exchange of blood and tissue cholesterol and an increase in choles­
terol excretion. It was suggested that the effects of parabiotic con­
nection may represent higher levels of hormone affecting excretion of 
cholesterol or, more likely, other properties of the young animal's 
blood which makes excretion of cholesterol easier; eg. less binding of 
cholesterol to blood lipoproteins. 
A decrease in the half-life of cholic and desoxycholic acid in rats 
during aging was not found (Beher et al., 1971). Hruza and Zbuzkova 
(1973) concluded from this and their own data that with aging conversion 
of cholesterol into bile acids and excretion of cholesterol itself is 
decreased, whereas once bile acids are formed, there is no difference 
in their excretion. 
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MATERIALS AND METHODS 
This study consists of two parts, both of which involved male rats 
of the Sprague-Dawley-Rolfsmeyer strain of two age groups, under ex­
ercised or nonexercised conditions and graded levels of thyroxine. In 
the first study the effects on several cardiovascular parameters were 
looked at, while in the second the effects on cholesterol turnover pools 
were studied. There were some differences in animal treatment between 
the two experiments, therefore, each will be discussed separately. 
Experiment 1: Cardiovascular 
Experimental design 
In the first experiment 142 animals were divided into two age 
groups: A young age group (Y) of 70 day old rats at the initiation of 
the study and a mature age group (M) of 200 day old rats at the experi­
ment's initiation. Both of the age groups were divided into five thyroid 
groups: 1) control (C)-thyroid intact; 2) Athyroid. (A) thyroidec-
tomized^ (T^) with no replacement thyroxine; 3) Hypothyroid (HQ)-T^ and 
subcutaneously (SQ) given 0.5 «g of L-thyroxine^, (L-T^X/lOO g BW/day; 
4) Physiologically hyperthyroid (Hy)-T^ and given 3.5 Hg L-T^/lOO g BW/day 
and 5) Pharmacologically hyperthyroid (PHy) -Tx and given 14 Hg L-T^/ 
100 g BW/day. 
^See Appendix A for the procedure of thyroidectomizing the rats. 
^See Appendix B for the procedure of preparing L-T4 solutions. 
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Each of the five levels of thyroid activity groups were further 
subdivided into two levels of physical activity: 1) nonexercised (NEsO 
and 2) exhaustive exercise (Ex) by swimming. 
Swimming technique 
Exercise was carried out five days per week for ten weeks, by 
individually swimming the rats in 20 gallon plastic tanks which were 
filled to a depth of approximately 25 inches with 35^2®C water. A 
wetting agent was added to the water to prevent the hair from trapping 
air. It was demonstrated by McArdle and Montoye (1966) that the re­
producibility of the swimming time to exhaustion was significantly im­
proved with a pre-training period. Therefore, a one week pre-training 
period was conducted by increasing in increments a lead weight which was 
attached to the rat's tail until a final weight of four percent of the 
animal's body weight was reached. This four percent added weight was 
maintained for the duration of the ten week exercise period to decrease 
the swimming time and to stimulate more vigorous swimming. A state of ex­
haustion was considered reached when the rat was unable to reach the sur­
face for ten seconds (Dawson and Horvath, 1970). Immediately following 
each exercise period the animals were rinsed to remove any of the wetting 
agent and partially dried with a towel before being returned to the cage. 
The rats were maintained in a temperature controlled, (25^2^0), 
artifically illuminated room (J8 A.M. to 10 P.M.). Drinking water and 
food (Wayne Lab-Blox basal diet) were provided ^  libitum. The rats 
were weighed each week and the lead tail weights were changed if 
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necessary. 
Experimental procedure 
At the termination of the ten week exercise period each rat was 
anesthetized with an intraperitoneal injection of sodium pentobarbital 
(40 mg/kg. Nembutal, Abbott Laboratories) and placed on its back with 
the limbs gently extended and taped in position. Rectal temperature 
was kept constant (38^1°C) with a heating pad. 
A midline incision was made through the abdominal wall of the rat 
and the underlying organs in the upper abdominal region were exposed. 
The abdominal aorta immediately distal to the diaphragm and the anterior 
superior mesenteric (ASM) artery were carefully exposed and freed of 
all connecting tissue. The ASM artery was cannulated with a 7.5 cm 
polyethylene catheter (PE-50, id .023 x od .038 inch), previously filled 
with heparinized saline, and connected to a Statham 23 Db blood pressure 
transducer. An electromagnetic flowmeter transducer (1.5 mm id, model 
SL-1, In Vivo Metric Systems) was placed around the abdominal aorta as 
close to the diaphragm as possible. It was secured into position to 
prevent movement. 
The signal from the Statham 23 Db blood pressure transducer was 
amplified by a Grass 505 amplifier, sent through a DC physiograph pre­
amplifier and recorded with an E and M Physiograph Four paper recorder. 
The electromagnetic flowmeter transducer was connected to a Biotronex BL-
610 pulsed logic flowmeter, which was also connected to the Physiograph 
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recorder via a DC preamplifier. Both measurements were recorded 
simultaneously on the Physiograph Four. 
Once all hemodynamic variables (arterial pressure and aortic flow 
velocity) were technically satisfactory following surgical preparation 
low speed (0.25 cm/sec) and high speed (10 cm/sec) tracings were re­
corded every five minutes for a one-half hour period. Before each 
recording the arterial blood pressure catheter was flushed with a small 
amount of heparinized saline by means of a three-way valve in the system. 
Arterial pressure was considered technically satisfactory only if the 
dicrotic notch was evident. It was also necessary to check and reset 
the zero flow position of the flowmeter before each recording. This 
was accomplished by momentarily stopping the flow of blood through the 
abdominal aorta by placing a small bulldog on the abdominal aorta distal 
to the flow probe for a few seconds. During this time the zero flow 
position was reset, ensuring a true flow recording. 
Recordings of pulse blood pressure was made at a frequency re­
sponse of 0->30 Hz and of pulse blood flow at a frequency response of 0-
100 Hz. Approximate levels of mean blood_pressure and mean blood flow 
were also possible by decreasing the frequency response in each case to 
IHz. 
The blood pressure transducer was calibrated prior to each ex­
perimental run with a column of water and expressed in terms of milli­
meters of mercury. The flowmeter system was calibrated periodically 
in situ using an intact abdominal aorta. To prepare the abdominal 
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aorta for calibration a rat was sacrificed and the aorta was canulated 
both in the thoracic region and the distal abdominal region. Warm, 
heparinized whole blood was perfused through the thoracic catheter 
at a pressure of 120 mn Hg and at different flow rates by controlling 
the flow with a valve on the abdominal catheter end. The flow rates 
were expressed in terms of ml/min. 
Measurements and calculations 
The experimental procedure permitted the direct determination from 
the paper recording of arterial mean (MBPRES), systolic (SBPRES) and 
diastolic (DBPRES); abdominal aortic mean (MBFLOW), systolic (SBFLOW) 
and diastolic (DBFLOW) blood flow and the heart rate (HRATE), which 
was determined by counting the number of heart beats over a ten second 
interval at three different times from the recording. Following 
sacrifice of the rat the heart was excised, cleaned, sealed in a plastic 
pouch and quick frozen in dry ice and acetone. At a later date the 
dry fat free weight of the heart (DHWT) was determined. 
From the direct determinations the following parameters could be 
calculated for each rat. Heart ratio (HRATIO), residual-DHWT (R-DHWT) 
residual-MBFLOW' (R-MBFLOW) abdominal aortic cardiac index (AGI), 
abdominal aortic systemic vascular resistance (ASVR) and ab­
dominal aortic stroke volume (ASVOL). It is acknowledged 
that several of these calculations (ÂCI, ASVR, and ASVOL) are 
modifications of calculations intended to be used with total 
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cardiac output measurements instead of with blood flow through 
the abdominal aorta only. However, the purpose of this study was to 
study the effects of age, exercise and thyroxine levels on the cardio­
vascular system, therefore, the comparisons made possible by using these 
formula are believed to be valid. 
The R-DHWT and R-MBFLOW values were calculated so comparisons 
could be made without the influence of body weight differences. This 
was accomplished by finding the regression equations for DHWT and 
MBFLOW, respectively, vs. the final body weight (FBWT) for all control, 
nonexercised rats. Using these two equations predicted values were cal­
culated for DHWT and MBFLOW for all the rats, using their final body 
weight. The predicted values for DHWT and MBFLOW were then subtracted 
from the actual values for DHWT and MBFLOW, respectively, to give the 
values for R-DHWT and R-MBFLOW. These values represent the changes in 
DHWT and MBFLOW due to the effect of the treatment only. 
Calculations made to determine the other parameters are shown below. 
1) HRATIO 25ÏÏI X 100 
FBWT 2/3 
2) Surface area • SA = 8 x FBWT 
3) AGI = MBFLOW/SA 
4) ASVR = MBPRES/ACI 
5) ASOV = MBFLOW/HRATE 
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Experiment 2: Cholesterol 
Experiment design 
The second experiment consisted of 147 animals, which were divided 
into the same two age groups. In this study each age group was divided 
into three thyroid groups: 1) control (C)-thyroid intact; 2) Athyroid 
(A)-T^ with no replacement thyroxine; and 3) Hyperthyroid (Hy)-!^ and 
given 7^g L-T4/IOO. g'BW/day. 
Both age groups of animals were also further divided into two 
levels of physical activity; 1) nonexercised (NE^O and 2) exhaustive 
exercise (Ex) by swimming. The swimming technique in this study was 
exactly the same as in the first except that no wetting agent was added 
to the water, a lead weight consisting of three percent of the rat's 
body weight was attached to the tail instead of a four percent weight 
and three to five animals were swum at a time in each plastic tank. 
The exclusion of the wetting agent was made because it was felt that 
the wetting agent may be contributing to increased respiratory 
difficulties. Several animals were swum at a time to cause interaction 
between the animals and consequently a more vigorous exercise. 
Experimental procedure 
On day 40 of the exercise program each rat was injected intra­
venously into the jugular vein with 4'^/100 g BW of ^ H-cholesterbl while 
under light ether anesthesia. The 1,2-%-cholesterol^ was prepared for 
^Amersham/Searle Co., Arlington Heights, Illinois. 
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injection by evaporating the toluene solution and redissolving it in a 
small amount of warm ethanol. Further dilution was made with physio­
logical saline solution. Evaporation of the %-cholesterol was always 
made in the same Pyrex flash, under laboratory temperature with the 
help of a stream of clean dry air (Hruza al. (1973). The radioactive 
solution was tested before injection and calculations made to ensure an 
injection dose of 4 pC/100 g BW. 
3 After the H-cholesterol administration one ml venous blood samples 
were withdrawn from the tail of the rat after 10 hours, 1, 2, 4, 7 days, 
thereafter at five day intervals and at the time the animals were 
sacrificed by decapitation. In each case the blood was collected in 
glass centrifuge tubes, allowed to clot, placed in the refrigerator 
for 24 hours, rimmed and centrifuged (1000 x g for 20 min). Serum was 
decanted into two dram vials, frozen and stored at -20°C. 
Determination of total serum cholesterol and radioactive cholesterol 
Serum total cholesterol was determined by the method of Mann (1961). 
A 0.2 ml portion of serum was transferred by a Levy-Lang constriction 
pipet, mixed with 5 ml of alcoholic KOH and saponified at 65°C for 
one hour. Exactly ten ml of petroleum ether (Skelly B) was added, 
vigorously shaken for one minute, then 5 ml of distilled water was 
added and vigorously shaken for one minute. When the petroleum ether 
layer separated two 4 ml aliquots of the nonsaponifiable lipids in the 
petroleum ether layer were taken. One aliquot was used to determine 
total cholesterol with an iron-sulfuric acid reagent (FeSac) and a 
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Spectronic 20 spectrophotometer read at 560 The other aliquot was 
dried out in glass scintillation bottles (plastic bottles absorb 
cholesterol), dissolved in toluene with one percent butyl-PBD and 
measured in a Bechman model LS-250 liquid scintillation counter (Hruza, 
1972). 
From the total serum cholesterol and the counts/min of radioactive 
cholesterol at each sampling time it was possible to analyze the data 
according to the method of Goodman and Noble (1968).^ 
To ensure that the % lable remained on the cholesterol and to 
check for cholesterol separation several thin layer chromatography 
(TLC) plates were made and the radioautograph technique was utilized. 
Analysis of the Data 
The data analysis was carried out using the Statistical Analysis 
System (Barr and Goodnight, 1971). The MEANS procedure was used to 
calculate the means and standard errors. The REGRESSION procedure was 
used to calculate the analysis of variance (ANOV), the R-DHWT and 
R-MBFLOW. The least significant differences (Isd) were calculated using 
the error mean square as the best estimate for the varience (Snedecor 
and Cochran, 1967). 
^A complete description of the cholesterol turnover curve analysis 
is given in Appendix C. 
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RESULTS 
The results of the two experiments conducted in this study will be 
presented separately. The variables involved in the cardiovascular 
study are shown in Table 2 and those involved in the cholesterol 
turnover pool study are shown in Table 12. The appropriate abbrevia­
tions and units are indicated. 
Experiment 1: Cardiovascular 
The results of this investigation, including means, standard 
errors of these means, least significant differences (Isd) and analyses 
of variance (ANOV), are presented in Table 3 through Table 11 and in 
Figures 2 through 6. 
Final body weight 
Thyroxine treatment had a highly significant (P<.0001) effect on 
FBWT, as shown in the ANOV (Table 3). There was a mean average decrease 
in FBWT in the athyroid young and mature rats, as compared to controls, 
of 30 and 13 percent respectively. As shown in Table 3, all athyroid 
rats exhibited a significant decrease in FBWT, as compared to controls, 
by an Isd test (P<0.05). 
With increasing levels of thyroxine the FBWT increased, then de­
creased again as higher levels were reached. The PHy rat's FBWT*s 
were reduced from control values by 23 and 17 percent, in the young and 
old rats, respectively. This decrease was significant in all PHy groups 
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Table.2. Parameters for the cardiovascular study 
Parameter 
Abbrevia­
tions Units 
Final body weight FBWT grams (g) 
Dry fat-free heart weight DHWT milligrams (mg) 
Re s idua1-DHWT R-DHWT mg 
Heart rate HRATE beats/minute (b/min) 
Mean blood flow MBFLOW milliliters/minute (ml/min) 
Re s idua1-MBFLOW R-MBFLOW ml/min 
Abdominal aortic stroke 
volume 
ASVOL ml/heart beat (ml/h.b.) 
Mean blood pressure MBPRES millimeters Hg (mm Hg) 
Abdominal aortic systemic 
vascular resistance 
ASVR mm Hg/ml/min/cm^ 
Other abbreviations 
Young rats Y 
Mature rats M 
Exercised Ex 
Nonexercised NEx 
Control G 
Athyroid A 
Hypothyroid Ho 
Hyperthyroid Hy 
"Pharmacologically" 
hyperthyroid 
PHy 
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Table 3. Means, standard errors of these means, least significant 
difference, and analysis of variance for final body weight 
(FBWT) 
Exercised Nonexercised 
Young (g) (g) 
Controls 398.3 - 14.9^ 428.0 - 14.9 
Athyroid 275.3 Ï 13.0 299.1 ^  25.9 
Hypothyroid 367.6 •t 10.0 381.3 ^  13.2 
Hyperthyroid 370.6 - 10.9 421.0 - 11.8 
P-Hyperthryo id 307.4 i 9.5 328.1 - 14.7 
Mature 
Controls 467.5 ^ 16.5 495.6 ^  25.0 
Athyroid 404.4 ^  17.5 438.2 t 18.5 
Hypothyroid 467.7 ^ 18.3 517.6 ^  16.9 
Hyperthyroid 431.0 ^ 22.1 440.2 -t 13.2 
P-Hyperthyroid 386.2 ^  17.8 418.1 ^  19.5 
Least significant difference at P<0.05 = 49.9 
Analysis of variance 
Source df F value Prob >F 
Age i 129.19 0.0001 
Exercise 1 11.70 0.0012 
Treatment 4 23.93 0.0001 
Age * Ex 1 0.32 n.s.b 
Age * Trt 4 3.36 0.0121 
Age * Ex * Ttt 4 0.49 n.s. 
^Mean standard error of the mean. 
bn.s. = not significant at P<0.05. 
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as indicated by Isd tests (P<0.05). 
Figure 2 illustrated that the weight reducing effect of high thy­
roxine levels does not affect the young rats until the highest (14 
microgram) dose of thyroxine is reached. In the mature rats, however, 
the smaller dose (3,5 micrograms) has exerted this weight reducing 
effect. 
Feed consumption was decreased in the A and Ho group, while it 
increased in the Hy and PHy groups. A rough estimation of this was 
noted in this experiment, although a precise measurement was not con­
ducted. Similar significant differences in feed consumption were re­
ported by Naito (1971). 
Gross examination of the animals conducted at the experiments 
conclusion indicated that the A rats were stunted in size and had 
normal, or above normal,deposits of fat in the abdominal cavity. 
The hyperthyroid rats, particularly the PHy group, were of normal size, 
but with a noticeable decrease in fat deposits. 
A small, but significant (P <0.0012) decrease was found in FBWT 
with exercise. The mean body weight for all exercised rats was 393.8 
grams as compared to 425.8 grams for nonexercised rats. No interaction, 
was found between age or thyroxine treatment with the effect of ex­
ercise in FBWT. Although a consistent decrease û£ FBWT was observed 
in all groups, it was significant with an Isd test (P<0.05) only in 
the Y-Hy and the M-Ho groups (Table 3). 
As would be expected there was a significant increase in FBWT 
with age as rats are considered to still be in a growth stage during 
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Figure 2. Final body weight vs logarithmic L-thyroxine concentration 
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the interval between the two ages studied. 
Heart weight 
A direct relationship was exhibited between thyroxine level and 
the weight of the heart. The mean DHWT (Table 4) for all control rats 
was 230.5 mg. There was a decrease of 34 percent in A rats to 151.5 mg, 
and an increase of 14.7 percent in PHy rats to 264.3 mg. 
The DHWT is related to FBWT as indicated by the correlation 
coefficient (R = 0.7231), which was significant at P<0.05. A cal­
culation of HRATIO's was considered to correct for the body weight 
effects, however, it has been convincingly demonstrated by Heroux and 
Gridgeman (1958) that HRATIO's are not a reliable means to compare 
changes in heart weight. Therefore, R-DHWT*s were calculated (Table 5), 
a brief explanation of which is given under Î4ATERIALS AND METHODS. The 
regression equation calculated from the DHWT's and FBWT's of all C-NEx 
rats was; 
predicted DHWT = 105.59 + 0.26256 x FBWT. 
By means of this equation the R-DHWT for all rats could be arrived at. 
The R-DHWT is the amount of change in the DHWT due to effects other than 
the change in FBWT. 
The effect of thyroxine treatment on R-DHWT is shown to be highly 
significant (P<0.0001) by the ANOV (Table 5). The Isd test also shows 
significant (P<0.05) differences in R-DHWT, as compared to controls, 
at all treatment levels except in the Y-Ho-Ex, Y-Hy-Ex and the M-Ho-Ex 
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Table 4. Means, standard errors of these means, least significant 
difference, and analysis of variance for dry heart weight 
(DHWT) 
Exercised Nonexercised 
Young (mg) (mg) 
Control 217.6 + 5.5® 218.3 6 .1 
Athyroid 131.7 + 6.5 130.3 t 13 .4 
Hypothyroid 186.2 7.8 166.0 ± 4 .7 
Hyperthyroid 222.8 + 5.8 255.2 t 14 .9 
P-Hyperthyroid 238.1 + 5.8 250.5 t 13 . 6 
Mature 
Control 250.5 + 7.0 235.4 - 8 .8 
Athyroid 182.5 + 6.0 161.3 ± 5 .5 
Hypothyroid 217.1 + 6.4 210.1 ^  3 .7 
Hyperthyroid 259.9 + 13.7 265.8 t 10 .9 
P-Hyperthyroid 272.6 + 13.5 296.1 ^  14 .7 
Least significant difference at P< 0.05 = 26.0 
Analysis of variance 
Source df F value Prob > F 
Age 1 40.58 0.0001 
Exercise 1 0.25 n.s.^ 
Treatment 4 91.90 0.0001 
Age * Ex 1 0.22 n. s. 
Age * xrt 4 6.37 0.0002 
Ex * Trt 4 3.16 0.0163 
Age * Ex * Trt 4 0.32 n.s. 
^Mean - standard error of the mean. 
^n.s. = not significant at P <0.05. 
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Table 5. Means, standard errors of these means, least significant 
differences, and analysis of variance for residual dry heart 
weight (R-DHWT) 
Exercised Nonexercised 
Youn# (mg) (rag) 
Control 7. ,42 + 4.26* 0.36 + 4. 32 
Athyroid -46. 20 + 3.87 -53.81 + 6. 98 
Hypothyroid -15. 87 + 7.49 -39.72 + 2. 82 
Hyperthyroid 19. 94 + 5.53 39.04 + 13. 38 
P-Hyperthyroid 51. 80 i- 3.77 58.74 10. 49 
Mature 
Control 13. 99 + 5.33 - 0.32 ± 5. 86 
Athyroid -29. 24 + 5.18 -59.34 ± 4. 21 
Hypothyroid -11. 27 + 5.24 -31.40 ± 4. 12 
Hyperthyroid 41. 16 + 9.13 44.67 ± 8. 76 
P-Hyperthyro id 65. 63 + 10.30 80.72 ± 12. 18 
Least significant differences at P< 0.05 = 20.02 
Analysis of variance 
Source df F value Prob> F 
Age 1 8.142 0.0053 
Exercise 1 3.219 0.0716 
Treatment 4 150.143 0.0001 
Age * Ex 1 1.055 n. s ._b 
Age * Trt 4 0.729 n. s •  
Ex * Trt 4 4.643 0.0019 
Age * Ex * Trt 4 0.769 n. s 
^Mean ^  standard error of the mean, 
^n.s. = not significant at P<0.05. 
groups. Treatment means showed decreases in R-DHWT of 21 and 10 per­
cent in A and Ho rats, respectively, and increases of 16 and 28 percent 
in Hy and PHy rats, respectively. Figure 3 illustrates the direct, 
almost linear, effect of thyroxine on R-DHWT. 
The hearts taken from the A rats at sacrifice had a "spongy" and 
soft characteristic to the muscle. In contrast, those from both hyper-
thyroid groups, especially the PHy group, had a noticeably more firm 
structure. 
On the basis of DHWT there was no significant change due to 
exercise, except between the Y-Hy-Ex and Y-Hy-NEx groups, using the Isd 
test (Table 4). Calculated on the basis of R-DHWT exercise caused a 
slight increase in heart weight, however, it only approached significance 
(P<0.0716) in the ANOV (Table 5). The C rats mean R-DHWT indicated 
an increase of 4.6 percent in heart weight with exercise, but it was 
not a significant increase. An interaction between exercise and thy­
roxine treatment was indicated by the ANOV. There was less of a de­
crease in heart weight in exercised A and Ho groups than in nonexercised 
A and Ho groups. However, less of an increase was found in the exercised 
Hy and PHy groups as compared to the respective nonexercised groups. 
As would be expected, due to the larger animal size, the DHWT 
increased from 203.6 mg in young rats to 230.1 mg in mature rats. 
On the basis of R-DHWT's there is not a significant (P<0.05) change 
in the heart weight of control rats due to age, as indicated by the 
Isd test (Table 5). However, there are greater increases in R-DHWT 
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in the mature Hy and Phy rats than in the same groups in the young. 
This accounts for the significant effect of age shown by the ANOV. 
Heart rate 
Heart rate changes with thyroxine treatment followed the same 
direct relationship as exhibited by heart weight (Table 6 and Figure 4). 
The ANOV shows a highly significant (P<0.0001) effect of thyroxine 
on HRATE. The mean heart rate for all C rats was 341 b/min. In the 
A rats this was decreased to 238 b/min, while the PHy rats showed an 
an increase to 468 b/min. Utilizing the Isd test (Table 6) there was 
a significant (P<0.05) difference in HRATE, as compared to controls 
in every group, except the Y-Hy-Ex, M-Hy-Ex and the M-Hy-NEx groups. 
The resting HRATE was decreased with exercise from 341 b/min in 
NEx rats to 327 b/min in Ex rats. The ANOV (Table 6) shows this 
effect to be significant (P<0.0043). Although the HRATE is slightly 
lowered in almost every group with exercise, the Isd test (Table 6) 
reveals a significant difference (P<0.05) only in the Y-Hy and Y-
PHy groups. The A and Ho groups showed little decrease and in some 
cases even slight increases in HRATE with exercise. The C rats ex­
hibited only small, insignificant, decreases in HRATE with exercise. 
HRATE was not found to be significantly influenced by the age 
differences present in this study, as shown by the mean HRATE's for the 
C-NEx rats of the two age groups and the ANOV (Table 6). 
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Table 6. Means, standard errors of these means, least significant 
difference, and analysis of variance for heart rate 
(HRATE) 
Exercised Nonexercised 
Young (b/min) (b/min) 
Control 333.1 + 10.62 343.0 ± 7. 8 
Athyroid 228.9 + 5.7 236.3 t 17. 2 
Hypothryoid 288.0 + 15.3 263.7 ^  11. 6 
Hyperthryoid 355.2 + 6.3 379.7 - 11. 7 
P-Hyperthyroid 436.6 + 13.9 480.9 ^ 13. 1 
Mature 
Control 340.0 8.2 345.6 ^ 6. 4 
Athyroid 247.0 + 12.9 236.1 5. 3 
Hypothyroid 274.7 ± 8.6 282.1 t 11. 5 
Hyperthyroid 351.0 ± 14.1 371.7 ^ 12. 0 
P-Hyperthyroid 466.0 + 7.8 484.5 1
+ 
o
 
8 
Least significant difference at P<0.05 = 30.23 
Analysis of variance 
Source df F value Prob> F 
Age 1 1.78 n. s. b 
Exercise 1 8.61 0.0043 
Treatment 4 262.11 0.0001 
Age * Ex 1 0.52 n.s. 
Age * Trt 4 0.61 n. s. 
Ex * Trt 4 1.32 n.s. 
Age * Ex * Trt 4 0.58 n.s. 
^Mean - standard error of the mean. 
^n.s. = not significant at P<0.05. 
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Blood flow parameters 
A direct, highly significant (P<0.0001) relationship with 
thyroxine treatment is shown by the MBFLOW means and ANOV (Table 7). 
Using total group means for MBFLOW through the abdominal aorta there 
was a 29 percent decrease in the A rats and a 60 percent increase in 
the PHy rats. The Isd test (Table 7) indicates that these differences 
are significant (P<0.05) in every case but one, the mature A-NEx 
group, when comparing the C to the A or PHy rats. 
Figure 5 shows a representative sample of actual pulsatile blood 
flow recordings for each of the 20 groups. 
Because it was felt that the size of the animal may be accounting 
for some of the differences seen in MBFLOW a regression analysis, 
similar to that used for DHWT, was undertaken for MBFLOW. The regres­
sion formula, using all C-NEx rat values for MBFLOW and FBWT, was: 
predicted MBFLOW = 3.865 + 0.04384 x FBWT. 
The residual MBFLOW (R-MBFLOW) was then calculated as the difference 
between the actual MBFLOW and predicted MBFLOW, for all rats. The 
R-MBFLOW values are shown in Table 8, as well as the ANOV, which 
indicates a highly significant (P<0.0001) effect of thyroxine treat­
ment. 
When determined as R-MBFLOW there was indicated a much smaller 
decrease in blood flow (4.1 percent) due to athyroidism, than shown by 
the MBFLOW values. The PHy group had an increase in blood flow, as 
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Table 7. Means, standard errors of these means, least significant 
difference, and analysis of variance for mean blood flow 
(MBFLOW) 
Excerised Nonexercised 
Young (ml/min) (ml/min) 
Control 23.71 + 1.11* 20.88 t 1.06 
Athyroid 13.42 + 1.24 13.04 t 1.06 
Hypothyroid 18.70 + 1.73 15.25 t 0.11 
Hyperthyroid 19.92 + 0.84 17.69 - 0.85 
P-Hyperthyroid 38.90 + 3.48 29.53 - 2.08 
Mature 
Control 33.51 + 1.91 27.14 t 1.55 
Athyroid 22.68 + 1.66 23.24 ± 1.88 
Hypothyroid 37.69 + 2.05 27.26 - 3.07 
Hyperthyroid 53.87 + 7.25 47.48 ^  1.73 
P-Hyperthyroid 59.22 + 5.31 42.35 ^  4.50 
Least significant difference at P<0.05 = 7.45 
Analysis of variance 
Source df F value Prob> F 
Age 1 140.01 0.0001 
Exercise 1 22.49 0.0001 
Treatment 4 41.68 0.0001 
Age * Ex 1 0.59 b n.s. 
Age * Trt 4 17.30 0.0001 
Ex * Trt 4 3.33 0.0126 
Age * Ex * Trt 4 0.93 n.s. 
®Mean standard error of the mean. 
^n.s. = not significant at P <0.05. 
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Figure 5. Representative recordings of abdominal aortic pulsatile 
blood flow for each treatment group 
75 
Table 8. Means, standard errors of these means, least significant 
difference, and analysis of variance for residual mean blood 
flow (R-MBFLOW) 
Exercised Nonexcerised 
Young (ml/min) (ml/min) 
Control 2.39 + 1.26* - 1.75 - 1.70 
Athyroid - 2.52 + 1.40 - 3.93 ^  0.50 
•Hypothyroid - 1.28 ± 1.40 - 5.33 Ï 0.59 
Hyperthyroid - 0.19 + 3.53 - 4.63 ^  0.65 
P-Hyperthyroid 21.56 3.53 11.28 * 2.22 
Mature 
Control 9.15 + 1.49 1.56 t 1.58 
Athyroid 1.08 + 1.15 0.17 Ï 2.11 
Hypothyroid 13.32 + 2.32 0.71 Ï 2.91 
Hyperthyroid 31.11 ± 6.43 24.32 ± 1.59 
P-Hyperthyroid 38.43 + 4.60 20.16 ^  3.76 
Least significant difference at P<0.05 = 6.88 
Analysis of variance 
Source df F value Prob> F 
Age 1 123.59 0.0001 
Exercise 1 39.70 0.0001 
Treatment 4 61.97 0.0001 
Age * Ex 1 3.81 n.s.b 
Age * Trt 4 16.60 0.0001 
Ex * Trt 4 3.67 0.0076 
Age * Ex * Trt 4 0.59 n.s. 
Q T" 
Mean - standard error or the mean. 
^n.s. = not significant at P <0.05. 
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determined by R-MBFLOW, of 82 percent, compared to controls. A smaller, 
but similiar, change was found in the PHy group for MBFLOW. 
It is of interest that, as was found with the effect of thyroxine 
on FBWT, the mature rats exhibited a sharp increase in blood flow at 
the 3.5 i^g level of thyroxine, while the younger rats were not greatly 
affected until the larger (14.0 fig thyroxine dose is reached. This is 
clearly shown by Figures 5 and 6, as well as in Tables 7 and 8. These 
differences due to age account for the significant interaction found 
between age and thyroxine treatment in the ANOV for both MBFLOW and 
R-MBFLOW in Tables 7 and 8. 
A value was also calculated for the amount of blood being pumped 
through the abdominal aorta with each heart beat, called the abdominal 
aortic stroke volume (ASVOL). The means shown in Table 9 indicate that 
the stroke volume is not changed as markedly with thyroxine treatment 
as MBFLOW or R-MBFLOW. The ANOV in the same table, shows a less sig­
nificant (P<0.0016) effect of thyroxine. The Isd test (Table 9) 
showed no significant differences in AS VOL, as compared to controls, in 
any of the thyroxine treatment groups in the young rats. The mature 
rats, however, showed significant (P<0.05) increases in ASVOL in the 
exercised Ho, Hy and PHy groups arid in the NEx-Hy group. These dif­
ferences account for the highly significant interaction between thy­
roxine treatment and age in the ANOV. 
The mean values for Ex and NEx MBFLOW values showed a 22 percent 
increase due to exercise, which was highly significant (P<0.0001) 
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Table 9. Means, standard errors of these means, least significant 
difference, and analysis of variance for abdominal aortic 
stroke volume (ASVOL) 
Exercised Nonexercised 
Young (ml/h.b. )x 10-2 (ml/h.b, .)xl0-2 
Control 7.20 - 0.49^ 6.07 + 0.50 
Athyroid 5.85 ^  0.49 5.59 + 0.38 
Hypothyroid 6.54 ^  0.65 5.85 ± 0.28 
Hyperthyroid 5.61 ^  0.79 4.71 + 0.43 
P-Hyperthyroid 8.94 ^  0.79 6.16 + 0.43 
Mature 
Control 9.93 ^  0.68 7.91 + 0.55 
Athyroid 9.50 ^  1.00 9.83 + 0.72 
Hypothyroid 13.81 ^ 0.85 9.68 0.94 
Hyperthyroid 15.61 ^  2.29 12.85 ± 0.66 
P-Hyperthyroid 12.77 t 1.27 8.73 ± 0.89 
Least significant difference at P<0.05 = 2.29 
Analysis of variance 
Source df F value Prob> F 
Age 1 152.73 0.0001 
Exercise 1 29.28 0.0001 
Treatment 4 4.81 0.0016 
Age * Ex 1 2.44 n.s. b 
Age * Trt 4 10.80 0.0001 
Mean - standard error of the mean. 
^n.s. = not significant at P<0.05. 
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according to the ANOV (Table 7). 
Calculated on the basis of R-MBFLOW there was a similiar (23 
percent) increase in blood flow with exercise when comparing all 
exercised rats with the nonexercised rats, and an increase of 22 per­
cent comparing the; exercised controls with the nonexercised controls. 
The difference in R-MBFLOW in the control rats was significant (P<0.05) 
with an Isd test only in the mature rats, however (Table 8). The over­
all effect of exercise on R-MBFLOW was found to be highly significant 
(P<0.0001) in the ANOV, in the same table, as well as an interaction 
between exercise and thyroxine treatment. 
A significant effect of exercise on R-MBFLOW was not found in 
the A groups. As the thyroxine level increased the effect of exercise 
on R-MBFLOW became significant (P<0.05) with the Isd test. This effect 
of increased R-MBFLOW due to exercise was demonstrated in the mature 
rats at lower thyroxine doses than in the young rats (Table 8). 
The abdominal aortic stroke volume (ASVOL) showed a similiar 
increase with exercise of 26 percent, which was also highly significant 
(P<0.0001) according to the ANOV (Table 9). The same changes were 
also noted in the young and mature rats, as well as no change occurring 
in the ASVOL of the A rats due to exercise and a larger increase (39.9 
percent) occurring in the PHy group. The Isd test showed a significant 
(P<0.05) increase due to exercise in the young PHy group and in the 
mature Ho, Hy and PHy groups, as compared to respective NEx rats. 
MBFLOW was significantly increased with age (Table 7), as would 
be expected, due to the larger body size. When using the R-MBFLOW 
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values (Table 8) there was still a highly significant (P<0.0001) 
increase in blood flow with age. This difference, however, between 
the overall means is due to the apparent increased effect of thyroxine 
in the mature rats, compared to the young, as the thyroxine dosage 
increases. At the lower thyroxine levels and in the control rats no 
significant difference in blood flow with age, as determined by 
R-MBFLOW, was found, using the Isd test (Table 8). 
The abdominal aortic stroke volume (ASVOL) is a derivative of 
MBFLOW, and is also significantly increased with age (Table 9). How­
ever, since body size would affect ASVOL this is not a valid comparison. 
Since heart rate was not found to be changed with the age differences 
in this study it can be conjectured that the changes in ASVOL with age, 
in this study, follows the same pattern as age effects on R-MBFLOW. 
Blood pressure 
Blood pressure was also found to be directly related to the 
thyroxine concentration and was found to be highly significantly 
(P<0.0001) related to the level of thyroxine in the ANOV (Table 10). 
There was a 13 percent decrease in MBPRES in the A rats as com­
pared to controls, and an increase of 8 percent in the PHy group. 
The Isd test (Table 10) showed a significant (P<0.05) decrease in 
MBPRES with athyroidism in all but the Y-Ex group, and a significant 
increase in MBPRES only in the Y-EHy-Ex group, although the Y-PHy-NEx 
group approached significance. 
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Table 10. Means, standard errors of these means, least significant 
difference,and analysis of variance for mean blood pressure 
(MBPRES) 
Exercised Nonexercised 
Young (mm Hg) (mm Hg) 
Control 125.6 + 4.3^ 131.5 
+ 
2.5 
Athyroid 116.2 + 3.7 109.9 + 5.4 
Hypothyroid 118.4 + 2.4 125.7 + 3.2 
Hyperthyroid 135.8 + 4.5 133.4 + 3.8 
P-Hyperthyroid 148.3 + 1.5 141.3 + 2.9 
Mature 
Control 119.3 + 3.6 127.6 + 1.9 
Athyroid 106.3 + 4.0 109.9 + 4.0 
Hypothyroid 112.7 + 4.7 117.6 + 5.2 
Hyperthyroid 114.0 + 4.6 127.2 + 3.2 
P-Hyperthyroid 124.0 + 3.1 128.3 + 2.2 
Least significant difference at P<0.05 = 10.6 
Analysis of variance 
Source df F value Prob > F 
Age 1 39.29 0.0001 
Exercise 1 4.24 0.0390 
Treatment 4 27.12 0.0001 
Age * Ex 1 5.54 0.0191 
Age * Trt 4 0.22 n.s.^ 
Ex * Trt 4 1.53 n. s ; 
Age * Ex * Trt 4 0.04 n. s. 
^Mean ^  standard error of the mean, 
^n.s. = not significant at P<0.05. 
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Exercise was found to have a slight, but significant (P<0.039) 
effect on MBPRES in the ANOV. The means (Table 10) indicate a small 
decrease in MBPRES with exercise in the C groups, however, only the 
mature Hy group had a significant (P<0.05) decrease in MBPRES due to 
exercise, using an Isd test. 
There was a decrease in the overall MBPRES's with age from 128.9 
mm Hg in young rats to 118.3 mm Hg in mature rats, which was sig­
nificant in the ANOV (Table 10). In rats which were exercised there 
was a greater decrease (12 percent) in MBPRES with age than in the non-
exercised rats (5 percent). This accounts for the significant inter­
action between age and exercise in the ANOV. There also appeared 
to be greater decreases in MBPRES with age as the thyroxine level was 
increased. The Isd test (Table 10) showed significant decreases in 
MBPRES with age only in the PHy groups and in the exercised Hy group. 
Peripheral resistance 
To arrive at an estimate of vascular resistance t*ie abdominal 
aortic systemic vascular resistance (ASVR) was calculated, which is the 
MBPRES divided by MBFLOW/surface area in cm^. The ANOV for ASVR shows 
a highly significant (P<0.0001) effect of thyroxine treatment 
(Table 11). The means, in the same table, demonstrate the inverse re­
lationship between vascular resistance and thyroxine level. 
Thyroxine treatment group means showed a 9 percent increase and a 
38 percent decrease in ASVR for A and PHy rats, respectively, compared 
to controls. The increase with athyroidism was most evident in the 
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Table 11. Means, standard errors of these means, least significant 
difference,and analysis of variance for abdominal aortic 
systemic vascular resistance (ASVR) 
Exercised Nonexercised 
Young (mm Hg/ml/min/cm2)xlO^ (mm Hg/ml/min/cm^)xl0 ' 
Control 234.6 t 
a 
18.9 300.1 + 23.6 
Athyroid 303.3 + 25.3 305.6 + 22.7 
Hypothyroid 268.9 + 25.4 345.7 ± 6.4 
Hyperthyroid 281.7 + 7.0 341.6 + 13.3 
P-Hyperthyroid 144.7 + 11.6 189.2 + 17.8 
Mature 
Contro1 174.4 + 9.8 240.4 + 15.1 
Athyroid 211.1 + 15.6 233.1 + 27.6 
Hypothyroid 148.7 + 13.5 241.2 + 27.5 
Hyperthyroid 105.2 + 14.4 124.9 + 6.8 
P-Hyperthyroid 91.1 + 7.1 143.5 + 12.5 
Least significant difference at P< 0.05 = 51.8 
Analysis of variance 
Source df F value Prob > F 
Age 1 119.61 0.0001 
Exercise 1 39.34 0.0001 
Treatment 4 21.84 0.0001 
Age * Trt 4 14.13 0.0001 
®Mean standard error of the mean. 
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exercised groups, with the Isd test (Table 11) showing a significant 
(P<0.05) increase in ASVR, compared to controls, only in the young 
A-Ex group. Significant (P<0.05) decreases in ASVR are shown with 
the Isd test in both Ex and NEx rats of the young PHy and the mature 
Hy and PHy groups. 
The ASVR was found to be highly significantly (P<0.0001) decreased 
with exercise in ANOV. The overall Ex and NEx means showed a 21 per­
cent decrease in ASVR due to exercise. Exercise significantly (P<0.05) 
lowered the ASVR in the C rats of both age groups, utilizing the Isd 
test. A significant decrease due to exercise was not shown in the 
athyroid rats, however. In the presence of thyroxine decreases in 
ASVR due to exercise once again occurred, as shown in Table 11. 
Age was shown to have a highly significant effect on ASVR aby the 
ANOV. There was a 22 percent decrease in ASVR with age in the control 
rats and the Isd test (Table 11) showed a significant (P<0.05) de­
crease with age in every group except the nonexercised PHy group. The 
large differences in body size with age may be partially responsible 
for these differences. 
Experiment 2: Cholesterol 
The results of this investigation, including means, standard errors 
of these means, least significant differences (Isd) and analysis of 
variance (ANOV), are presented in Tables 13 through 28. The parameters 
for the cholesterol study are shown in Table 12. 
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Table 12. Parameters for the cholesterol study-
Parameter 
Abbrevia­
tion Units 
Final body weight 
Total serum cholesterol 
Cholesterol pool A 
%/lOOg of FBWT 
Cholesterol pool B 
Mg/lOOg of FBWT 
Production rate of new 
cholesterol into pool A 
P%/100g B.W. 
Rate constant of cholesterol 
transfer from pool A to B 
Rate constant of cholesterol 
transfer from pool B to A 
Rate constant of total 
cholesterol removal 
from pool A 
Rate constant of loss of 
cholesterol from pool A 
Rate of removal of cholesterol 
from pool A 
r^/lOOg B.W. 
Metabolic clearance 
rate of cholesterol 
Metabolic clearance 
percentage of 
cholesterol 
FBWT 
S-CHOL 
^A 
%/lOOg B.W. 
Mb 
Mg/lOOg B.W. 
PR* 
PR^/lOOg B.W. 
AB 
BA 
^AA 
r^/lOOg B.W. 
MCR 
MOP 
grams (g) 
milligrams/100 ml. serum 
(mg- 7o) 
mg 
mg/lOOg B.W. 
mg 
mg/lOOg B.W. 
mg/day 
mg/day/lOOg B.W. 
per day (/day) 
/day 
/day 
/day 
mg/day 
mg/day/lOOg B.W. 
milliliters of serum per 
day (ml serum/day) 
percent of serum volume 
cleared per day 
(% serum/day) 
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Final body weight 
The changes with FBWT in the second experiment followed the same 
pattern as that shown in the first with age, exercise and thyroid 
levels (Table 13). The ANOV indicated significant relationships with 
FBWT due to age, exercise and thyroxine treatment. The treatment means, 
shown in the same table, show decreases in body weight due to exercise, 
athyroidism and hyperthyroidism. There was a greater decrease in FBWT 
due to athyroidism than to hyperthyroidism in the young rats, while 
the opposite was true in the mature rats. 
Total serum cholesterol 
The ANOV (Table 14) indicated a highly significant (P<0.0001) 
effect of thyroxine level on S-CHOL. A t-test showed a significant 
increase in the athyroid and a decrease in the hyperthyroid rats com­
pared to controls at the P<0.025 level. The means are shown in Table 
14. The Isd test for individual group means showed a significant dif­
ference from their respective controls only in the mature Ex-A group 
and in the mature NEx-Hy group. 
Exercise was found to significantly (P<0.0123) influence the 
S-CHOL in the ANOV (Table 14). However, the Isd test (Table 14) showed 
no significant difference between any of the individual treatment groups. 
A t-test showed a significant (P<0.05) lowering of S-CHOL only in the 
mature control group. In the athyroid groups of both ages there was 
actually an increase in S-CHOL with exercise. These changes account 
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Table 13- Means, standard errors of these means, least significant 
difference, and analysis of variance for final body weight 
(FBWT) 
Exercised Nonexercised 
Young (g) (g) 
Control 374.0 - 7.2® 400.8 - 10.3 
Athyroid 300.4 - 14.6 281.5 - 6.3 
Hyperthyroid 338.2 t 13.2 347.2 t 14.3 
Mature 
Control 466.1 t 9.5 513.1 - 7.4 
Athyroid 413.2 ± 20.6 445.0 * 7.1 
Hyperthyroid 385.4 ± 16.7 420.0 ^  12.0 
Least significant difference at P<0.05 = 32. 32 (for above means) 
Exercise Means Ex: 381.7 NEx: 404.2 
Age Means Y: 336.5 M: 446.0 
Treatment Means C: 449.0 A: 359.5 Hy: 375.4 
Analysis of variance 
Source df F value Prob > F 
Age 1 268.86 0.0001 
Exercise 1 11.12 0.0015 
Treatment 2 70.69 0.0001 
Age * Ex 1 4.95 b n. s. 
Age * Ex * Trt 2 2.86 U. S .  
®Mean 'i' standard error of the mean, 
^n.s. - not significant at P< 0.05. 
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Table 14. Means, standard errors of these means, least significant 
difference, and analysis of variance for mg percent of total 
serum cholesterol (S-ŒOL) 
Exercised Nonexercised 
Young (mg 7o) (mg 7.) 
Control 
Athyroid 
Hyperthyroid 
64.19 
71.17 
60.85 
t  4.71® 
-  2.70 
^ 4.25 
66.82 
70.26 
61.91 
-  2.91 
^ 3.17 
^ 3.73 
Mature 
. 
Control 
Athyroid 
Hyperthyroid 
65.43 
82.76 
60.13 
-  3.25 
^ 3.78 
-  3.34 
73.28 
76.10 
62.68 
-  4.56 
^ 3.84 
-  2.70 
Least significant difference at P < 0.05 = 10. 23 (for above means) 
Exercise Means Ex: 67.34 NEx: 69.24 
Age Means Y: 66.51 M: 70.15 
Treatment Means C; 68.00 A: 74. 46 Hy: 61.46 
Analysis of variance 
Source 
Age 1 
Ex 1 
Trt 2 
Age * Ex 1 
Age * Trt 2 
Ex * Trt 2 
Age * Ex * Trt 2 
F value 
23.17 
6 . 2 2  
96.87 
3,63 
10.99 
7.29 
6.42 
Prob > F 
0.0001 
0.0123 
0.0001 
n. s.^ 
0.0001 
0.0011 
0.0021 
a + 
Mean - standard error of the mean. 
n.s. = not significant at P< 0.05, 
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for the significant interaction between exercised and thyroxine treat­
ment shown by the ANOV. 
Age was found to have a highly significant influence on S-CHOI 
in the ANOV. The age means show a slight increase in S-CHOL with age. 
The Isd test, however, showed a significant (P< 0.05) increase with 
age only between the A-Ex groups. No significant increase with age 
was found in the exercised C and Hy groups, or in the nonexercised Hy 
group. There were larger, but insignificant, increases in S-CHOL with 
age in the nonexercised C and A groups. 
Cholesterol pools A and B 
is the size of the rapidly exchangeable cholesterol pool (pool 
A). Because a significant (P< 0.0003) correlation was found between 
and FBWT this parameter was also calculated as M^/lOOg B.W. The ANOV 
(Tables 15 and 16) for both and M^^/lOOg B.W. show a significant re­
lationship with thyroxine treatment. Overall means for (Table 15) 
show a decrease in with athyroidism and an increase with hyper­
thyroidism. Calculated as M^/lOOg B.W. the decrease with athyroidism 
is no longer evident, although an increase with hyperthyroidism is still 
indicated. 
There is a significant interaction between age and thyroxine treat­
ment shown in both ANOV. The young rats show significant (P< 0.05) de­
creases in with athyroidism, as indicated by the Isd test (Table 15), 
and insignificant decreases in with hyperthyroidism. The mature 
animals showed a significant (P<0,05) decrease in with athyroidism 
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Table 15. Means, standard errors of these means, least significant 
difference, and analysis of variance for the size of pool 
A (%) 
Exercised Nonexercised 
Young (mg) (mg) 
Control 125. 53 ^  8.00^ 135.93 + 8.97 
Athyroid 81. 30 t 7.51 94.23 + 2.48 
Hyperthyroid 105. 60 - 10.84 125.05 + 8.39 
Mature 
Control 113. 65 ^  4.57 120.34 + 4.88 
Athyroid 89. 60 ^  5.14 117.24 ± 6.69 
Hyperthyroid 162. 15 t 11.49 235.24 + 11.45 
Least significant difference at P< 0.05 = 21.59 (for above means) 
Exercise Means 
Age Means 
Treatment Means 
Analysis of variance 
Source 
Age 
Exercise 
Treatment 
Age * Ex 
Age * Trt 
Ex * Trt 
Age * Ex * Trt 
^Mean standard error of the mean. 
^n.s. = not significant at P<0.05. 
Ex: 112.18 NEx: 134,68 
Y: 109.82 M: 138.49 
C: 123.56 A: 97.59 Hy: 161.22 
df F value Prob>F 
1 41.31 0.0001 
1 25.02 0.0001 
2 66.64 0.0001 
1 2.19 n.s.^ 
2 36.61 0.0001 
2 8.03 0.0008 
2 5.14 0.0072 
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Table 16. Means, standard errors of these means, least significant 
difference, and analysis of variance for the size of pool 
A/lOOg B.W. (%/lOOg B.W.) 
Exercised Nonexercised 
Young (mg/lOOg B.W.) (mg/lOOg B.W.) 
Contro1 33.50 + 1.86® 33.88 ^  1.93 
Athyroid 27.11 ± 1.96 33.72 t 1.18 
Hyperthyroid 30.95 + 2.62 36.01 ^  1.78 
Mature 
Contro1 24.39 + 0.89 23.49 ^  0.97 
Athyroid 21.76 ± 0.94 26.23 ^  1.23 
Hyperthyroid 42.85 + 3.50 56.35 ^  2.90 
Least significant difference at P< 0.05 = 5.26 (for above means) 
Exercise Means Ex: 29.75 NEx: 33.94 
Age Means Y: 32.49 M: 31.84 
Treatment Means C: 28.05 A 27.78 Hy: 42.38 
Analysis of variance 
Source df F value Prob > F 
Age 1 0.36 n.s.b 
Exercise 1 14.65 0.0004 
Treatment 2 73.71 0.0001 
Age * Ex 1 0.04 n.s. 
Age * Trt 2 51.35 0.0001 
Ex * Trt 2 6.67 0.0021 
Age * Ex * Trt 2 4.53 0.0123 
^Mean ^  standard error of the mean, 
^n.s. = not significant at P< 0.05. 
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only in the exercised group, while both hyperthyroid groups had large, 
significant increases in Calculated as M^/lOOg B.W. (Table 16) 
the young rats showed no significant changes except for a slight, but 
significant, decrease in the exercised, athyroid group. The mature rats 
again had large increases in with hyperthyroidism, but no sig­
nificant difference in the athyroid groups. 
On the basis of age alone the ANOV for showed a highly sig­
nificant relationship. The means are shown in Table 15, which indicate 
an increase in with age. Calculated as Mj^/lOOg B.W., however, there 
was no difference in the size of pool A with age. 
The ANOV indicated a significant relationship between exercise 
and both and M^^/lOOg B.W. ; with the means showing a decrease with 
exercise in both cases. There was also an interaction with thyroxine 
indicated, however. The control rats did not show significant (P< 0.05) 
decreases in or ï^/lOOg B.W. in either age with exercise. Sig:-
nificant decreases in were shown in the mature A and Hy groups, and 
in %/lOOg B.W. in the young A and Hy groups and the mature Hy group. 
Mg is the size of the slowly exhangeable cholesterol pool. The 
size of Mg can be calculated if the basic assumption is made that both 
the synthesis (Sg) and the rate constant (kg) for excretion from pool B 
are zero. This gives a minimal value for Mg (Nestel et.» 1969; 
Wilson, 1970). A significant (P<0.0004) correlation was found between 
Mg and FBWT, therefore it was also calculated as Mg/lOOg B.W. 
When calculated as Mg there was no significant relationship in­
dicated between Mg and thyroxine treatment in the ANOV (Table 17). 
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Table 17. Means, standard errors of these means, least significant 
difference, and analysis of variance for the size of pool 
B (Mg) 
Exercised Nonexercised 
Young (mg) (mg) 
Control 163.01 t  73.7# 175.05 ^ 8.01 
Athyroid 
Hyperthyroid 
160.81 
149.18 
-  13.14 
^ 15.43 
175.35 -  14.52 
153.08 ^ 13.31 
Mature 
Control 194.98 7.45 185.97 ^ 12.03 
Athyroid 171.12 -  12.30 219.23 -  11.85 
Hyperthyroid 188.18 -  7.61 269.08 ^ 21.47 
Least significant difference at P<0.05 = 36. 70 (for above means) 
Exercise Means Ex: 198.66 NEx: 213.60 
Age Means Y: 164.33 M: 206.22 
Treatment Means C: 182.22 A: 184. 96 Hy: 193.62 
Analysis of variance 
Source df F value Prob> F 
Age 1 30.52 0.0001 
Exercise 1 9.30 0.0031 
Treatment 2 0.77 n. s .b 
Age * Ex 1 2.92 n. s. 
Age * Trt 2 5.40 0.0058 
Ex * Trt 2 3.59 0.0294 
Age * Ex * Trt 2 3.14 0.0453 
®Mean "i" standard error of the mean. 
^n. s. = not significant at P<0.05. 
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When calculated as Mg/lOOg B.W., however, there was a highly significant 
relationship shown in the ANOV (Table 18). 
The treatment means indicate an increase in Mg/lOOg B.W. in both 
the A and the Hy groups compared to controls. There was a significant 
interaction between age and treatment, however. The individual group 
means show an increase in Mg/lOOg B.W. in only the young A groups, 
while increases occurred in the NEx-A and both Hy groups in the mature 
rats. 
The ANOV (Table 17) showed a significant (P< 0.0031) decrease in 
Mg due to exercise, however, calculated as Mg/lOOg B.W. the slight de­
crease due to exercise was not significant in the ANOV (Table 18). 
There was no interaction between either age or thyroxine treatment on 
the exercise effects indicated in the Mg/lOOg B.W. ANOV. 
Although there was a significant relationship between age and 
Mg indicated by the ANOV this difference was evidently due to the dif­
ferent body weights as Mg/lOOg B.W. showed no significant effect due 
to age. 
It must be remembered that this value for Mg is a minimal value, 
calculated considering no synthesis of cholesterol by the tissues of 
pool B. 
Production rate of cholesterol 
PR^ is the production rate of appearance of new cholesterol in 
pool A, exclusive of that recycled from it, and it is assumed to ap­
proximate the total turnover rate. Because a correlation approaching 
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Table 18. Means, standard errors of these means, least significant 
difference, and analysis"of variance for the size of pool 
B/lOOg B.W. (Mg/lOOg B.W.) 
Exercised Nonexercised 
Young (mg/lOOg B.W.) (mg/lOOg B.W.) 
Control 43.34 
+ 
3.14^ 43.81 
+ 
1.95 
Athyroid 54.55 + 4.69 62.67 + 5.38 
Hyperthyroid 43.78 + 3.78 44.36 + 3.61 
Mature 
Control 
Athyroid 
Hyperthyroid 
41.98 T 1.67 
41.84 t 3.21 
50.27 t 4.06 
36.35 ^  2.45 
49.17 * 2.47 
64.48 ^  5.33 
Least significant difference at P< 0.05 = 10.39 (for above means) 
Exercise Means Ex: 46.41 NEx: 49.96 
Age Means Y; 49.97 M: 47.08 
Treatment Means C: 41.00 A: 52.99 Hy: 51.37 
Analysis of variance 
Source df 
Age 1 
Exercise 1 
Treatment 2 
Age * Ex 1 
Age * Trt 2 
Ex * Trt 2 
Age * Ex * Trt 2 
F value 
1.81 
2.68 
12.61 
0.11 
11.70 
2.13 
2.89 
Prob > F 
b 
n. s. 
0.0998 
0.0001 
n. s. 
0.0001 
n.s. 
n.s. 
^Mean ^  standard error of the mean. 
n.s. = not significant at P< 0.05. 
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significance (P<0.0682) was found between and FBWT a calculation 
was made for PR^/lOOg B.¥. 
The ANOV for both PRa (Table 19) and PR^/lOOg B.W. (Table 20) 
show a highly significant relationship with thyroxine treatment. The 
treatment means, shown in the same tables, show a decrease in both 
parameters with athyroidism and an increase with hyperthyroidism. 
The increase with hyperthyroidism is quite large and significant 
(P<0.05) in every individual group using the Isd test, although the 
increase was slightly greater in the mature rats (Tables 19 and 20). 
Athyroidism showed a significant decrease in each individual group for 
PR^ except the mature NEx-A rats, using the Isd test, however, the de­
crease was significant for PR^/lOOg B.W. only in the young Ex-A group. 
These differences explain the significant interaction found between 
age and thyroxine treatment in both ANOV. 
The effect of age was significant on P%, but not on PR^/lOOg B.W., 
according to the ANOV. A closer inspection of PR^/lOGg B.W. reveals, 
however, that there is a significant (P<0.05) decrease due to age when 
the control rats of each age group are compared, using the Isd test 
(Table 20). A larger increase in PR^/lOOg B.W. in the mature Hy groups, 
than in the young Hy groups, partially explains the nonsignificance 
with the overall age means. 
Exercise did not appear to affect the production rate. Although 
there was a significant relationship shown for PR^, when a correction 
was made for body weight (P%/100g B.W.) exercise was no longer sig­
nificant. 
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Table 19. Means, standard errors of these means, least significant 
difference, and analysis of variance for the production 
rate of new cholesterol into pool A (PR^) 
Exercised Nonexercised 
Young (mg/day) (mg/day) 
Control 31.66 t 3. if 33.01 ^  2.62 
Athyroid 18.91 t 1.81 17.65 ^ 0.83 
Hyperthyroid 41.97 t 4.72 54.17 ^  3.72 
Mature 
Control 27.50 - 1.21 29.04 - 1.57 
Athyroid 19.76 ^  1.36 23.12 t 1.71 
Hyperthyroid 54.53 i 3.17 76.37 ^  4.98 
Least significant difference at P< 0.05 = 7. 40 (for above means) 
Exercise Means Ex: 31.87 NEx: 36.52 
Age Means Y: 31.42 M: 37.28 
Treatment Means C: 30.09 A: 20.03 Hy: 57.90 
Analysis of variance 
Source df F value Prob> F 
Age I 14.70 0.0004 
Exercise 1 9.12 0.0034 
Treatment 2 209.54 0.0001 
Age * Ex 1 0.62 n.s.b 
Age * Trt 2 13.64 0.0001 
Ex * Trt 2 13.69 0.0001 
Age * Ex * Trt 2 2.36 n.s. 
Mean - standard error of the mean. 
^n.s. = not significant at P< 0.05. 
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Table 20. Means, standard errors of these means, least significant 
difference, and analysis of variance for production 
rate/lOOg B.W. (PR^/lOOg B.W.) 
Exercised Nonexcerised 
Young 
Control 
A thyroid 
Hyperthyroid 
Mature 
Control 
Athyroid 
Hyperthyroid 
(mg/d/lOOg B.W.) 
8.44 - 0.7# 
6.22 t 0.39 
12.31 t 1.07 
5.92 - 0.26 
4.76 - 0.20 
14.37 ^  0.95 
(mg/d/lOOg B.W.) 
8.19 - 0.56 
6.31 ^  0.33 
15.93 ^  1.36 
5.68 - 0.33 
5.14 - 0.30 
18.26 - 1.19 
Least significant difference at P<0.05 = 1.90 (for above means 
Exercise Means 
Age Means 
Treatment Means 
Ex: 8.48 
Y: 9.21 
C: 6.84 A: 5.66 
NEx: 9.24 
M: 8.66 
Hy: 15.43 
Analysis of variance 
Source df 
Age 1 
Exercise 1 
Treatment 2 
Age * Ex 1 
Age * Trt 2 
Ex * Trt 2 
Age * Ex * Trt 2 
F value 
1.93 
3.65 
230.68 
0.19 
11.72 
11.19 
0.47 
Prob> F 
n.s.b 
n. s. 
0.0001 
n.s. 
0.0001 
0.0001 
U . S .  
Mean - standard error of the mean, 
^n.s. = not significant at P< 0.05. 
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Rate constants of cholesterol 
The value is the rate constant for cholesterol transfer from 
pool A to pool B. This constant is possible to calculate if it is 
assumed that kg equals zero. 
Thyroxine treatment had a significant (P<0.0025) effect on 
k^B as indicated by the ANOV (Table 21). The treatment means, shown 
in the same table, indicate an increase with athyroidism and a decrease 
with hypothyroidism for k^g. The increase with athyroidism, however, 
was significant (P<0.05) only in the young Ex-A group when testing 
the individual groups with an Isd test, although the increase in the 
young NEx-A group approached significance. There was a significant 
(P<0.05) decrease with hyperthyroidism only in the mature NEx-Hy group, 
utilizing the Isd test, a slight decrease in the mature NEx-Hy and 
actually increases in both young Hy groups. The above tests are all 
made against the respective controls. These differences explain the 
significant interaction between age and thyroxine treatment shown in 
the ANOV. 
Age was not found to have a significant effect on k^g in the ANOV. 
However, if only the control animals are looked at there was a sig­
nificant (P<0.05) increase in k^g with age in the Ex-C groups, and an 
increase approaching significance in the NEx-C groups, utilizing the 
Isd test. 
Exercise was shown to have a significant effect on k^g by the ANOV 
(Table 21). However, exercise did not appear to affect this parameter 
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Table 21. Means, standard errors of these means, least significant 
difference, and analysis of variance for the rate constant 
of cholesterol transfer from pool A to B (k^g) 
Exercised Nonexcerised 
Young 
Control 
Athyroid 
Hyperthyroid 
(/day) 
0.1702 ^  0.0131^ 
0.2443 ^  0.0168 
0.2216 ^  0.0067 
(/day) 
0.1863 - 0.0073 
0.2130 ^  0.0155 
0.1937 ^  0.0113 
Mature 
Control 
Athyroid 
Hyperthyroid 
0.2140 ^  0.0091 
0.2368 ± 0.0188 
0.1984 t 0.0147 
0.2121 t 0.0105 
0.1914 ^  0.0075 
0.1464 ^  0.0062 
Least significant difference at P< 0.05 = 0.0335 (for above means) 
Exercise Means 
Age Means 
Treatment Means 
Ex: 0.2170 
Y: 0.2072 
NEx; 0.1920 
M: 0.1988 
C: 0.1996 A; 0.2177 Hy: 0.1875 
Analysis of variance 
Source df 
Age 1 
Exercise 1 
Treatment 2 
Age * Ex 1 
Age * Trt 2 
Ex * Trt 2 
Age * Ex * Trt 2 
F value 
1.48 
12.86 
6.44 
0.45 
8.18 
4.28 
0.36 
Prob > F 
n.s.b 
0.0008 
0.0025 
n.s. 
0.0007 
0.0156 
n.s. 
^Mean ^  standard error of the mean. 
'n.s. = not significant at P< 0.05. 
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in the control animals, while it increased it in both the athyroid and 
hyperthyroid groups of both ages. 
The value kg^ is the rate constant for the transfer of cholesterol 
from pool B to pool A. If kg (the rate constant for excretion from 
pool B) is assumed to be zero, then kg^ = -kgg, where kgg is the rate 
constant for total cholesterol removal from pool B. 
The ANOV (Table 22) shows a highly significant (P<0.0001) re­
lationship between k^A and thyroxine treatment. The treatment means, 
shown in the same table, show a decrease in k^ with athyroidism and 
an increase with hyperthyroidism, compared to controls. 
The changes seen with age and exercise were not significant at 
the P<0.05 level in the ANOV. The Isd test showed a significant 
(P<0.05) increase in kg^ with exercise in the mature A and Hy groups, 
and a slight, but insignificant, increase with exercise was also seen 
in the young A group. In contrast, both C groups and the young Hy 
group showed slight, insignificant, decreases in kg^ with exercise. 
These differences account for the significant interaction between 
exercise and treatment in the ANOV. 
The value k^ is the rate constant for the total removal of 
cholesterol from pool A. If the assumption is made that kg = 0, then, 
^AA = -(^A + k^g). 
Thyroxine treatment was found to significantly affect k^ in the 
ANOV (Table 23). The treatment means, in the same table, indicate that 
this relationship is mainly due to an increase in k^ with hyperthyroid­
ism. This effect was found principally in the young animals, thus 
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Table 22. Means, standard errors of these means and least significant 
difference, and analysis of variance for the rate constant 
of cholesterol transfer from pool B to A (kg^) 
Exercised Nonexercised 
Young 
Control 
Athyroid 
Hyperthyroid 
(/day) 
0.1315 ^  0.0084* 
0.1248 - 0.0095 
0.1568 ^  0.0058 
(/day) 
0.1430 ^  0.0063 
0.1148 - 0.0049 
0.1618 - 0.0108 
Mature 
Control 
Athyroid 
Hyperthyroid 
0.1244 t 0.0052 
0.1249 - 0.0084 
0.1655 i 0.0078 
0.1403 - 0.0080 
0.1038 ^  0.0059 
0.1299 ^ 0.0057 
Least significant difference at P< 0.05 = 0.0205 (for above means) 
Exercised Means Ex: 0.1372 NEx: 0.1301 
Y: 0.1371 M: 0.1297 
C: 0.1354 A: 0.1154 Hy: 0.1528 
Age Means 
Treatment Means 
Analysis of variance 
Source df 
Age 1 
Exercise 1 
Treatment 2 
Age * Ex 1 
Age * Trt 2 
Ex * Trt 2 
Age * Ex * Trt 2 
F value 
3.06 
2.70 
25.87 
3.46 
0.88  
5.41 
1.55 
Prob> F 
n.s.^ 
n.s. 
0.0001 
n.s. 
n.s. 
0.0058 
n.s. 
^Mean ^  standard error of the mean, 
^n.s. = not significant at P<0.05. 
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Table 23. Means, standard errors of these means, least significant 
difference, and analysis of variance for the rate constant of 
total cholesterol removal from pool A (k^) 
Exercised Nonexercised 
Young 
Control 
Athyroid 
Hyperthyroid 
(/day) 
-0.3895 t 0.0158* 
-0.4582 ± 0.0286 
-0.5838 ^  0.0272 
(/day) 
-0.4004 ^  0.0181 
-0.3802 ^  0.0184 
-0.5948 ^  0.0330 
Mature 
Control 
Athyroid 
Hyperthyroid 
-0.4321 t 0.0175 
-0.4348 ^  0.0258 
-0.4994 t 0.0288 
-0.4244 T 0.0136 
-0.3703 ^  0.0172 
-0.4361 ^  0.0182 
Least significant difference at P<0.05 = 0.0615 (for above means) 
Exercise Means 
Age Means 
Treatment Means 
Ex: -0.4666 NEx: 0.42 
Y: -0.4607 M: -0.4276 
0: -0.4150 A: -0.4050 Hy: -0.5238 
Analysis of variance 
Source df F value Prob> F 
Age 1 6.81 0.0099 
Exercise 1 10.24 0.0021 
Treatment 2 33.65 0.0001 
Age * Ex 1 0.55 n.s.b 
Age * Trt 2 12.05 0.0001 
Ex * Trt 2 1.47 n.s. 
Age * Ex * Trt 2 0.87 n.s. 
^Mean ^  standard error of the mean, 
^n.s. = not significant at P< 0.05. 
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accounting for the significant age-treatment interaction in the ANOV. 
The ANOV also indicated a significant effect of exercise on k^. 
The Isd test showed a significant (P<0.05) increase with exercise in 
the young A group and the mature A and Hy groups; neither young nor 
mature control groups showed significant differences due to exercise. 
Age was also found to significantly affect in the ANOV. The 
age means indicated a larger k^ in the young rats. However, the 
difference due to age was significant (P<0.05), with the Isd test, only 
between the Hy groups of both ages. 
The values k^, r^ and r^/lOOg B.W. are all related and presented 
together. The rate constant k^ is that of loss from pool A, and from 
the whole system if kg is assumed to be zero. The amount of loss from 
pool A/day is measured in mg as r^. Because the correlation between 
r^ and FBWT approached significance (P<0-0642) a calculation was also 
made for r^/lOOg B.W. 
Thyroxine treatment has a highly significant (P<0.0001) effect 
on all three parameters according to the appropriate ANOV (Tables 24, 
25, and 26). The treatment means for k^ (Table 24) indicate a decrease 
with hyperthyroidism, compared to controls. The increase with hyper­
thyroidism was largest in the young animals. The treatment means for 
r^ and r^/lOOg B.W. showed similar changes as for k^, although the 
decrease with athyroidism was not large when calculated as r^/lOOg B.W. 
The larger increase due to hyperthyroidism in the young rats for k^ 
was not evident for r^/lOOg B.W. 
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Table 24. Means, standard errors of these means, least significant 
difference, and analysis of variance for the rate constant 
of loss of cholesterol from pool A (k^) 
Exercised Nonexercised 
Young 
Control 
Athyroid 
Hyperthyroid 
Mature 
Control 
Athyroid 
Hyperthyroid 
(/day) 
0.2194 t 0.0119* 
0.2139 ^  0.0156 
0.3621 t 0.0265 
0.2181 - 0.0101 
0.1980 t 0.0104 
(/day) 
0.2141 - 0.0122 
0.1672 t 0.0071 
0.4011 t 0.0343 
0.2122 T 0.0070 
0.1789 ^  0.0107 
0.2897 ^  0.0143 0.3010 ^  0.0156 
Least significant difference at P< 0.05 = 0.0426 (for above means) 
Excerise Means Ex: 0.2496 NEx: 0.2336 
Y: 0.2535 M: 0.2288 
C; 0.2154 A; 0.1873 Hy: 0.3362 
Age Means 
Treatment Means 
Analysis of variance 
Source 
Age 1 
Exercise 1 
Treatment 2 
Age * Ex 1 
Age * Trt 2 
Ex * Trt 2 
Age * Ex * Trt 2 
F value 
7.89 
3.25 
101.97 
0.27 
10.84 
1.49 
1.33 
Prob > F 
0.0059 
n.s.b 
0.0001 
n.s. 
0.0001 
n.s. 
n. s. 
^Mean ^ standard error of the mean, 
^n.s. = not significant at P<0.05. 
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Table 25. Means, standard errors of these means, least significant 
difference, and analysis of variance for the rate of 
movement of cholesterol from pool A (r^) 
Exercised Nonexercised 
Young (mg/day) (mg/day) 
Control 27. 82 + 2.88* 28.68 - 2.22 
Athyroid 16. 91 + 1.55 15.73 f 0.73 
Hyperthyroid 37. 56 + 4.23 48.69 Ï 3.37 
Mature 
Control 24. 47 + 1.10 25.55 - 1.37 
Athyroid 17. 64 + 1.17 20.69 - 1.52 
Hyperthyroid 47. 77 + 2.81 68.00 Ï 4.71 
Least significant difference at P< 0.05 = 6.68 (for above means) 
Exercise Means Ex: 28. 25 NEx: 32.43 
Age Means Y: 27. 91 M: 33.05 
Treatment Means C: 26. 44 A: 17.89 Hy: 51.52 
Analysis of variance 
Source df F value Prob > F 
Age 1 13.90 0.0005 
Exercise 1 9.03 0.0035 
Treatment 2 203.73 0.0001 
Age * Ex 1 0.72 b n.s. 
Age * Trt 2 11.58 0.0001 
Ex * Trt 2 14.45 0.0001 
Age * Ex * Trt 2 2.47 n. s. 
a + 
Mean - standard error of the mean. 
n.s. = not significant at P<0.05. 
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Table 26. Means, standard errors of these means, least significant 
difference, and analysis of variance for the rate of removal 
of cholesterol from pool A per lOOg B.W. (r^/lOOg B.W.) 
Exercised Nonexercised 
Young (mg/day/lOOg B.W.) (mg/day/lOOg B.W.) 
Control 7.42 + 0.70* 7.12 t 0.35 
Athyroid 5.57 + 0.37 5.62 ^  0.33 
Hyperthyroid 11.02 + 0.54 14.38 ^  0.44 
Mature 
Control 5.27 
+ 
0.35 5.00 - 0.33 
Athyroid 4.26 + 0.54 4.60 ^  0.29 
Hyperthyroid 12.60 + 0.44 16.27 ^  0.41 
Least significant difference at P<0.05 = 1. 79 (for above means) 
Exercise Means Ex: 7.52 NEx: 8.22 
Age Means Y: 8.20 M: 7.68 
Treatment Means C: 6.00 A: 5.06 Hy: 13.75 
Analysis of variance 
Source df F value Prob > F 
Age 1 1.99 n.s.b 
Exercise 1 3.55 n. s. 
Treatment 2 213.47 0.0001 
Age * Ex 1 0.08 n.s. 
Age * Trt 2 9.15 0.0004 
Ex * Trt 2 11.47 0.0001 
Age * Ex * Trt 2 0.52 n.s. 
Mean - standard error of the mean. 
'n.s. = not significant at P<0.05. 
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Age had a significant effect on according to the ANOV (Table 
24). Upon closer inspection it was found that this difference in age 
was principally due to the larger increase in the young Hy group. 
The controls were not significantly different due to age when tested 
with the Isd test. However, although the ANOV for r^/lOOg B.W. did 
not show significance due to age, the Isd test does show a significant 
(P<0.05) decrease in r^/lOOg B.W. with age in the control rats. 
Exercise was shown to significantly affect r^ by the ANOV (Table 
25), however, this effect was evidently due to body weight changes as 
neither nor r^/lOOg B.W. showed significant effects due to exercise 
in each respective ANOV (Table 24 and 26). 
Metabolic clearance of cholesterol 
MCR is the metabolic clearance rate of cholesterol from pool A, 
expressed as a volume of plasma. This value is related to MCP, which 
is the percentage of the blood volume cleared of cholesterol each day. 
The results of these two parameters will be presented together. 
Both MCR and MCP show a highly significant (P<0.0001) relation­
ship with thyroxine treatment in the respective ANOV (Tables 27 and 28). 
The treatment means for both parameters, in the same tables, show a de­
crease with athyroidism and a .marked increase with hyperthyroidism. 
The Isd test indicated a significant (P< 0.05) decrease in MCP 
with athyroidism only in the exercised groups, as compared to respective 
controls. There were significant (P<0.05) increases in MCP with 
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Table 27. Means, standard errors of these means, least significant 
difference, and analysis of variance for the metabolic 
clearance rate (MCR) 
Exercised Nonexercised 
Young (ml serum/day) (ml serum/day) 
Control 48.94 + 3.04a 50.30 Ï 4.71 
Athyroid 26.81 + 2.73 25.69 t 1.83 
Hyperthyroid 69.87 + 8.57 90.11 Ï 8.15 
Mature 
Control 43.44 + 2.68 42.16 Ï 5.14 
Athyroid 23.80 ± 1.31 32.23 t 3.35 
Hyperthyroid 92.10 t 6.57 122.62 t 8.29 
Least significant difference at P<0.05 = 14. 24 (for above means' 
Exercise Means Ex: 50.08 NEx: 56.34 
Age Means Y: 49.29 M: 57.53 
Treatment Means C: 45.74 A: 27. 70 Hy: 95.46 
Analysis of variance 
Source df F value Prob > F 
Age 1 7.85 0.0060 
Exercise 1 4.45 0.0345 
Treatment 2 180.98 0.0001 
Age * Ex 1 0.19 
b 
n.s. 
Age * Trt 2 9.57 0.0003 
Ex * Trt 2 8.59 0.0006 
Age * Ex * Trt 2 1.44 n.s. 
^ean ^  standard error of the mean, 
^n.s. = not significant at P<0.05. 
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Table 28. Means, standard errors of these means, least significant 
difference, and analysis of variance of the metabolic 
clearance percentage (MCP) 
Exercised Nonexercised 
Young (% serum/day) (% serum/day) 
Control 437 + 28^ 416 + 34 
Athyroid 292 + 19 306 + 22 
Hyperthyro id 682 + 66 905 + 125 
Mature 
Control 311 
+ 
19 276 
+ 
36 
Athyroid 193 + 9 237 + 21 
Hyperthyro id 807 + 59 979 ± 69 
Least significant difference at P<0.05 = 136 (for above means) 
Exercise Means 
Age Means 
Treatment Means 
Ex: 444 
Y; 484 
C: 348 A: 262 
NEx: 480 
M: 447 
Hy: 854 
Analysis of variance 
Source df 
Age 1 
Exercise 1 
Treatment 2 
Age * Ex 1 
Age * Trt 2 
Ex * Trt 2 
Age * Ex * Trt 2 
F value 
1.64 
1.57 
162.25 
0.68 
5.70 
6.19 
0.30 
Prob > F 
b 
n.s. 
n.s. 
0.0001 
n.s. 
0.0046 
0.0031 
n.s. 
^Mean ^  standard error of the mean, 
^n.s. = not significant at P<0.05. 
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hyperthyroidism in all cases, using the Isd test, although larger 
increases appeared in the nonexercised groups (Table 28). 
MCR indicates a significant relationship with age and exercise in 
the ANOV (Table 27). This was partly due to the differences in body 
weight, as reflected in the blood volumes, because, when calculated as 
MCP, there were no significant differences due to age or exercise in­
dicated by the ANOV (Table 28). There was a significant (P<0.05) 
decrease in MCP with age in the NEx-C rats, however, and a decrease 
in the Ex-C rats with age which approached significance, using the 
Isd test. In contrast, the hyperthyroid mature rats had higher MCP 
values than hyperthyroid young rats. This accounts for the significant 
age-treatment interaction in the ANOV (Table 28). 
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DISCUSSION 
The discussion will be divided into two basic parts. The first 
will cover the experiment on the cardiovascular parameters and the 
second will cover the experiment on cholesterol turnover pools. 
Experiment 1: Cardiovascular 
Final body weight 
The increase in FBWT (Table 3) with age over the age limits of 
this study were as expected. A similar increase with the same strain 
of rat and age differences was reported by Story (1972) and Long (1974). 
Long also found that both age groups were still growing at the ex­
periments termination for each, although the young rats were gaining 
more rapidly (15. g/week) than the mature rats (2g/week). 
The decrease in body weight due to exercise is similar to that 
found by Long (1974), Naito (1971) and Story (1972). Story also re­
ported an increase in thyroid secretion rate (TSR) with exercise. 
However, since exercise resulted in the same degree of decrease in 
FBWT at all thyroid levels after thyroidectomy in this study, it would 
appear that the increased TSR found with exercise is not responsible 
for the decrease in body weight associated with exercise. This is 
supported by the study of Tipton et al. (1968), where exercised 
thyroidectomized rats showed a decrease in FBWT compared to nonexercised 
thyroidectomized rats. 
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Hanson et al. (1967) and Jones et al. (1964) have previously 
reported that the decrease in body weight with chronic exercise is due 
to loses in body fat. Examination of the rats at the time of sacrifice 
in the present study confirmed this finding, although precise measure­
ments of body fat were not conducted. 
The decrease in FBWT observed in this study with athyroidism and 
hyperthyroidism, especially in the PHy group, has been observed before 
by Long (1974), Naito (1971), and Story (1972). 
The dependence of thyroxine and growth hormone for normal growth 
(Beck et al., 1946), particularly in regard to protein synthesis, is 
a likely cause for the stunted growth observed in the A rats. Although 
food intake was decreased in the A rats (Naito, 1971), it has been 
demonstrated by Scow (1951) that thyroidectomized rats, forced-fed 
to achieve near normal weight gain, did so by increasing the adipose 
tissue and not the lean body mass. 
The effect of excess thyroxine is an increased metabolic rate, as 
shown in Cohen's et (1966) study, where a greater oxygen consumption 
occurred with thyroxine fed mice. This effect could lead to the de­
creased FBWT observed with hyperthyroidism, where decreased deposits 
of fat were evident. 
A decrease in body weight due to thyrotoxicosis occurring at a 
lower dose level of thyroxine in the mature than in the young rats has 
not been previously reported. It has been suggested by Grad and Hoffman 
(1955) that certain tissues may become more sensitive to thyroxine with 
age in rats. It is possible, therefore, that some thyroxine stimulated 
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metabolic mechansim is more sensitive in the mature than in the young 
rats, leading to the results observed with FBWT. 
Heart weight 
Although the DHWT (Table 4) is significantly correlated with FBWT 
(R = 0.7232), the correlation would have to be near to a perfect cor­
relation for the heart ratio value to be accurate. Therefore, the 
residual-dry heart weights (Table 5) were presented as a more accurate 
means to compare for changes in heart weight, although DHWT and heart 
ratio values do add information. 
The increase in DHWT with age is similar to that found by Story 
(1972) and Tomanek £t ^  (1972), and is expected considering the in­
crease in FBWT. However, utilizing the R-DHWT's there was not found 
to be a significant difference in heart weight between the young and 
mature control rats. This finding supports that of Korenchevsky 1961), 
who found that in humans, unlike the other organs, no decrease in heart 
weight was found with age. 
Although there was not found to be an effect of exercise on the 
DHWT, the R-DHWT's indicated an increase in heart weight which was 
not significant, but did approach significance (P<0.0716). Story 
(1972) reported a significant increase in heart weight with exercise 
using a regression procedure for analysis, as did Tipton and Tcheng 
(1971). 
It appears, therefore, that in rats exercise may cause some 
cardiac hypertrophy, however, the effect may not be as marked as 
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reported by some investigators who have used heart ratios for compari­
son. It is also possible that the exercise method employed in this 
study was of insufficient duration and degree to promote significant 
cardiac hypertrophy. 
In relationship to age this study did not indicate a significant 
difference in the response of cardiac hypertrophy to exercise. A 
study by Bloor et^ (1970), however, indicated that hypertrophy did 
occur with exercise in four week old rats, there was no change in heart 
weight of three to four month old rats and there was a decrease in 
heart weight with exercise in rats over one year old. In the young 
rats the hypertrophy was associated with increases in the sarcoplasmic 
mass and in the number of myocardial fibers, while decreases in both of 
the parameters were said to be found in the old rats. The age differences 
in rats between Bloor*s study and this one are the probable cause for 
the different results. 
The direct relationship between heart weight and the level of 
thyroxine was the most marked of the parameters tested for effect on 
heart weight. In both age groups there was a decrease in R-DHWT com­
pared to controls in the A and Ho groups, while there was an increase 
in both ages in the Hy and PHy groups. This effect has been shown 
by numerous investigators (Bartosova et al., 1969; Beznak, 1962; Cohen 
e£ a^. , 1966; Mowery and Lindsay, 1973). 
The mechanism related to the changes in heart weight associated 
with varing thyroxine levels is likely to be associated with protein 
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synthesis. Bartosova et al. (1969) and Inchiosa and Freedberg (1965) 
found the greatest effect of thyroxine to be on contractile protein, 
with less of an effect on noncontractile protein and collagen synthesis. 
Cohen et a^. (1966) also reported an increased incorporation of 
leucine-^^C into total myocardial protein in mice within 48 hours of 
thyroxine administration. 
In relation to exercise no increase in heart weight was found with 
exercise in the Hy and PHy groups. In contrast, there was actually 
greater hypertrophy of the heart in the nonexercised rats of the Hy and 
PHy groups. This difference was not significant, however, as tested 
with the Isd test. These results are supported by those of Tipton and 
Tcheng (1971), who reported similar increases in heart weight of both 
trained and nontrained hypophysectomized rats given thyroid stimulating 
hormone (TSH). The results of Tipton and Tcheng also do not support the 
concept that growth hormone is essential for cardiac hypertrophy to 
occur in hypophysectomized rats. 
In relation to age similar changes were seen with R-DHWT in both 
young and mature rats, although cardiac hypertrophy appeared to be 
greater in the mature Hy and PHy groups than in the same young age 
groups. Florini et al^. (1973) reported similar dose response curves 
in 8 and 26 month old rats for cardiac hypertrophy with thyroxine. 
However, they also found a longer lag period before hypertrophy occurred 
in older mice. 
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Heart rate 
Although the HEATE (Table 6) did decrease a slight amount with age, 
from 338 b/min in the young rats to 332 b/min in the; mature, the change 
was not significant. Other investigators, however, have observed a 
decrease in heart rate with age (Lee et al. 1972; Lin and Horvath, 
1972; and Tipton and Taylor, 1965), as well as an increase followed by a 
decrease with age (Berg, 1955). It is possible that the age differences 
present in this study were not sufficient to lead to HRATE changes. 
Exercise did exhibit a small, but significant, decrease in HRATE. 
Several investigators have reported similar decreases (Clark, 1927; 
Marsland, 1968; and Tipton, 1965). The exact mechanism behind the de­
crease in heart rate with age is not known, although it appears that 
alterations in the autonomic nervous system or neuro-transmitters in the 
heart are responsible (Gollnick and Simmons, 1967; Herrlich et al., 1960; 
Lin and Horvath, 1972; Raab et , 1960; Schryver et al^., 1969; and 
Tipton and Taylor, 1965). The level of thyroxine had some influence on 
the effect of exercise to decrease the HRATE as the greatest decrease 
in HRATE occurred at the "pharmacological" hyperthyroid level, while 
the athyroid level did not show any decrease in HRATE with exercise. 
The changes in HRATE due to thyroxine level differences were the 
most noticeable. The almost linear response of increased HRATE (Figure 
4), which was also shown by Mowery and Lindsay (1973), to increasing 
thyroxine levels is interesting in that it is similiar to the linear 
dose related increase in heart weight (Figure 3). The other parameters 
affected in this study by thyroxine, eq. FBWT and blood flow, did not 
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follow a similiar linear response. This finding supports the current 
view that thyroxine directly affects the heart (Anton and Gravenstein, 
1970; Van'der Schoot and Moran, 1965; and Wilson et al., 1566), the p-
adrenergic receptors (Pietras et , 1972) or the SA node and impair­
ment of vagal inhibition (Heimback and Grout, 1972; Shimada and Oshima, 
1973) to increase the heart rate. 
Blood flow parameters 
A significant increase in blood flow was found with age when all 
treatment groups of the two age levels were compared for MBFLOW (Table 
7) and R-MBFLOW (Table 8). However, when looking at only the control 
animals age did not significantly change the R-MBFLOW. The change was 
significant for MBFLOW only between the exercised control animals, and 
not between the nonexercised young and mature controls. 
The values obtained for MBFLOW are similar to those obtained by 
Lee e£ £l. (1972). Lee also used an electromagnetic flowmeter to de­
termine blood flow, however, the probe was placed around the ascending 
aorta, as close to the heart as possible. The values obtained by Lee 
for 6, 12 and 24 month old rats were 40.8, 43.5 and 41.3 ml/min. Con­
sidering that the values presented in the present study were made by 
placing the flow probe around the abdominal aorta the values for control 
animals are similar to those of Lee. When calculated on the basis of 
ml/min per kg Lee found a slight increase in blood flow between the 6 
and 12 month old rats. 
The control rats in the present study (young-140 days and mature-270 
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days) also showed a slight increase in blood flow with age. 
Small, but insignificant, increases in stroke volume (Table 9) 
were also found by Lee and in the present study between the ages 
mentioned above. 
With greater age (24 months), however, Lee et al^. (1972) found a 
decrease in blood flow calculated as ml/min per kg. This finding is 
supported by that of Rothbaum et al. (1973), who used the RbCl indica­
tor dilution method to determine cardiac output in 12 and 24 month old 
rats. Rothbaum also found a decrease in stroke volume with age. 
Coupled with a previous finding that left ventricular weight and volume 
increased with senescence, Rothbaum suggested an age-related decrease 
in the ability to maintain output per heart beat. 
It appears, from the data of this study and others, that the 
mature rats used in this study have not reached the age where a de­
crease in blood flow is evident. 
Increases of around 20 percent were found when comparing the 
exercised control with the nonexercised control rats for MBFLOW, R-
MBFLOW and ASVOL. These changes in control animals were significant 
with the Isd test only in the mature rats, however, for R-MBFLOW, 
although the others all approached significance. 
Similiar increases in blood flow with exercise has been presented 
by Penpargkul and Scheuer (1970), using cardiac output of perfused 
hearts. They suggest that the improved condition of the heart with 
exercise is partially due to improved oxygen delivery. 
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The increased blood flow with exercise in both age groups of rats 
appeared even though heart rate and blood pressure decreased. There was 
also a decrease in vascular resistance and a slight hypertrophy of the 
heart with exercise. All of these findings together suggest that the 
exercised heart is functionally superior to the normal, nonexercised 
one. 
Considering the increase in blood flow with exercise at the various 
thyroxine levels it is interesting that there is no significant change 
in blood flow at the athyroid level in either age group, while increasing 
dosages of thyroxine apparently increase the possible effect of exercise 
on blood flow. Coupled with the finding of Story (1972) that exercise 
increases the thyroid secretion rate (TSR), it is possible that thyroxine 
is necessary for the increase in blood flow with exercise and in the 
normal, intact, rat the increase in TSR may be partly responsible for 
the increase in blood flow seen with training by exercise. 
The direct relationship between thyroxine level and blood flow 
is highly apparent from the present study. This effect, or related 
effects, have been presented before in numerous studies (Amidi et al. 
1968; Beznak, 1962; Freedberg and Hamolsky, 1974; and Pietras et al. 
1972). 
Beznak presented one ;of the few studies on the effect of graded 
thyroxine dose levels on various cardiovascular parameters. She found 
direct, near linear, increases in cardiac output, oxygen consumption, 
heart weight, systolic blood pressure, stroke volume and minute work with 
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seven increasing dosages of thyroxine varing from 0.0375 to 5.8875 mg 
of thyroxine injected subcutaneously per week. It was concluded by 
Beznak that hemodynamica1ly the increase in blood flow is the result of 
a faster heart rate and a greater stroke volume. This study substanti­
ated the change in heart rate as partly responsible for differences 
in blood flow due to thyroxine, however, similar changes in stroke 
volume were not found in the young rats. A decrease in peripheral 
resistance with increased thyroxine levels was also found by Beznak, 
as was found in the present study, which may also hemodynamically affect 
the blood flow. 
The mechanism behind the effect of thyroxine on the heart is not 
known, although it is thought to be a direct action of thyroxine on 
the heart and not due to any indirect effects, like oxygen consumption 
or catecholamine response (Amidi et al., 1968; Braunwald et al., 1969; 
Cohen et al., 1973; Freedberg and Hamolsky, 1974; Hoch, 1971; Ismail-
Beigi and Edelman, 1971; Levey and Epstein, 1969; Paterson, 1971; and 
Sokolof f et. 9 1968). Several of these mechanism are discussed in 
the LITERATURE REVIEW. 
The marked difference in the response of the mature compared to 
the young rats to the hyperthyroid (3.5 pg) level of thyroxine on blood 
flow, as found with FBWT, supports the hypothesis presented by Grad 
and Hoffman (1955) that the sensitivity of certain tissues to thyroxine 
may increase with age. 
The changes in heart rate and heart weight in relation to in­
creasing thyroxine levels, however, do not follow the same pattern. 
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Instead, both heart rate and heart weight show near linear increases 
with increased thyroxine levels in both age groups of rats. It is 
suggested, therefore, that the possible tissues in the mature animal 
showing increased sensitivity to thyroxine do not include the heart. 
It is further speculated that the mechanism of thyroxine action 
on blood flow is not totally dependent upon its action on the heart. 
Instead, other mechanisms of thyroid action are probably involved in 
blood flow changes, like the effect of thyroxine on the peripheral 
blood vessels (Theilen and Wilson, 1967). 
Blood pressure 
Although a slight increase with age was found by Lee e£ al. 
(1972) of mean arterial blood pressure in 6, 12 and 24 month old rats, 
a significant decrease with age was found in this study from 129 mmg Hg 
in young rats to 118 mm Hg in mature rats (Table 10). This finding is 
supported by the work of Rothbaum e^ al. (1973) who also found a 
decrease in mean blood pressure from 114 mm Hg in 12 month old rats to 
105 mm Hg in 24 month old rats. Rothbaum also noted that P-adrenergic 
blockade abolished the slight decrease in blood pressure due to age. 
These findings in rats are in conflict with those demonstrated in 
humans (Hallock, 1934), where an increase occurs in blood pressure 
with age. It is possible that the increasing blood pressure found in 
man with age is related to the disease of atherosclerosis and not to 
aging, or that the older rats in the above studies were actually selected 
animals, with those having the higher blood pressures dying early. 
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Training appeared to cause a slight, but insignificant, decrease 
in MBPRES in this study. Crews and Aldinger (1967) did not find a 
decrease in blood pressure in rats after swimming for six hours per 
day for three to seven weeks, however, they did point out that other 
researchers had found a slight lowering of systolic pressure and an 
elevation of diastolic pressure in trained subjects. 
The changes in blood pressure with different thyroxine levels in­
cluded a decrease with athyroidism and a linear increase with thyroxine 
administration. 
These findings are in conflict with some human findings. Amidi 
et al. (1968) reported an increase in brachial artery pressure from 
81 mm Hg in control subjects to 93 and 90 mm Hg in hypothyroid and 
hyperthyroid subjects, respectively. In their review Freedberg and 
Hamolsky (1974) reported that elevation of blood pressure had been 
observed in some patients with myxedema, and thyroid treatment had 
resulted in a lowering of blood pressure. 
Other work using rats as experimental animals support the findings 
of this study, however. Beznak (1962) found an increase in systolic 
blood pressure from about 145 mm Hg to over 200 mm Hg with increasing 
levels of thyroxine. Field e^ a^. (1973) reported a decrease in MBPRES 
with thyroidectomy from 121 mm Hg before treatment to 97 mm Hg; as well 
as an increase to 133 mm Hg after thyroxine injections. In this study 
changes were noted from a control value for MBPRES of 126 mm Hg to values 
of 110 and 136 mm Hg for A and PHy rats, respectively. 
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Field £t al. (1973) also reported that the aorta from hyperthyroid 
and hypothyroid rats were suprasensitive and subsensitive, respectively, 
to low doses of nbrephinphrine and KCI. This suggested that thyroxine 
does not alter vascular response by acting specifically at the adrener­
gic receptors, but that an alteration does occur. Such changes in 
vascular sensitivity appear in conflict with the fact that hyperthyroid­
ism decreases peripheral resistance while hypothyroidism increases it. 
(Freedberg and Hamolsky, 1974). It is possible that a second factor, 
the ability of the kidney to control blood pressure, is involved. A 
further discussion of this topic is continued in this report under 
peripheral resistance. 
Peripheral resistance 
The changes in abdominal aortic systemic vascular resistance are 
directly related to changes in MBPRES and inversely related to blood 
flow. In this study age indicated a decrease in ASVR (Table 11), as 
would be expected from the results found for MBPRES and blood flow. 
The results of Lee et al. (1972) support these findings. In rats 
6 and 12 months old Lee found a slight decrease in peripheral resistance 
with age. 
With greater age, however, both Lee et aj^. (1972) and Rothbaum 
et al. (1973) found an increase in peripheral resistance in 24 month 
old rats. These findings are supported by human studies (Landowne 
et al., 1955 and Roach and Burton, 1959) where a loss in elasticity of 
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old arteries and an increase in peripheral resistance with age were 
reported. 
It appears that the age differences in rats of this study were not 
great enough to exhibit the decrease in peripheral resistance commonly 
associated with old age. Instead, the cardiovascular system is still 
in a state of growth and the adverse conditions of old age are not 
present yet. 
With exercise the control rats demonstrated decreased MBPRES and 
increased blood flow. The decrease in ASVR with exercise found in this 
study would, therefore, be expected. The mechanisms involved in changes 
in MBPRES and blood flow with exercise, as already discussed, will play 
a part in the changes seen with peripheral resistance. Other possible 
causes include an alteration in the autonomic nervous system, as sug­
gested by Lin and Horvath (1972) in the heart, where a greater re­
duction in sympathetic tone, than of parasympathetic tone occurred 
with exercise training. An increase in vascularity, capillary mass or 
changes in arteriovenous anastomoses may also occur to promote a decrease 
in peripheral resistance with exercise. 
There is a direct relationship between both MBPRES and blood flow 
with thyroxine levels, ie. there is a decrease in both with athyroidism 
and increases as the thyroxine dosage level increases. The changes in 
blood flow are greater, however, therefore there is a decrease in 
peripheral resistance as measured by ASVR with increasing thyroxine 
levels, and an increase in ASVR with athyroidism. 
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These results are supported by those of Beznak (1962), Field 
et al. (1973), Kontos et a^. (1965), Rosenquist and Boreus (1972), 
Theilen and Wilson (1967), and Zaimis et al. (1965). 
The mechanism behind the action of thyroxine on peripheral re­
sistance is not known. It has been suggested that the response may be 
associated with the alpha-adrenergic response of arteries, however. 
Field e^ a^. (1973) presented data to suggest that the response is not 
specifically at the adrenergic receptor. 
Whatever the mechanism which is involved the data of this study 
and others suggest that the hemodynamic effects of peripheral vaso­
constriction and vasodilation associated with thyroxine levels is at 
least in part responsible for changes in peripheral resistance and 
blood flow, as discussed previously. 
Experiment 2: Cholesterol 
Final body weight 
The changes found in FBWT (Table 13) in this phase of the study 
are similiar to those found in the cardiovascular study, therefore, 
it will not be discussed again. 
Total serum cholesterol 
The changes in total serum cholesterol concentration (Table 14) 
found in this study due to age, exercise and different thyroxine levels 
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follow similiar patterns reported fay other investigators. 
The increase in S-CHOL found with age is supported by Carlson et 
al. (1968) and Story (1972). In view of the fact that decreased syn­
thesis (Block et al., 1946; Trout e^ al•j 1962) and decreased gastro­
intestinal absorption (Yamamoto and Yamamura, 1971) of cholesterol have 
been reported with age, the following proposals have been presented 
as possible explainations of the increase in serum cholesterol with age. 
1) A common mechanism causing imbalance between rates of synthesis 
and degradation of cholesterol, not involving degradation to bile acids 
or the feed-back control mechanism of cholesterol synthesis to dietary 
cholesterol (Carlson e^ al., 1968). 
2) A decreased thyroid secretion rate with age which parallels 
the increased lipid concentrations (Story, 1972). 
3) A slowing of the acidic steriod to fecal steriod step in 
cholesterol turnover of older rats (Dupont ^  ajL., 1972). 
4) A decreased biliary and fecal excretion of cholesterol and its 
metabolites; (Yamamoto and Yamamura, 1971). 
5) A change in some blood property, eq. a more firm binding of 
cholesterol to lipoproteins, may lead to the observed decrease in 
excretion and exchange between blood and tissues of cholesterol with 
age. Of the latter two only excretion is increased with thyroxine or 
growth hormone (Hruza e£ al., 1973). 
6) The accumulation of cholesterol in the circulation with age is 
probably secondary in part to excessive production of triglycerides 
(Bierman, 1973). 
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The decrease, although slight, of S-CHOL with exercise in this 
study is supported by the reports of Monsen et al. (1972); Papadopoulos 
et al. Û.969^ Story and Griffith, (1972% and Watt et al. (1972)... There 
have been reports of no decrease in serum cholestdrol with exercise, 
however, (Paris et al., 1971; Hughes £t al., 1971). 
Several possible mechanisms have been presented for the decrease 
in serum cholesterol with exercise. 1) An increase in the side chain 
cleavage of cholesterol associated with muscular contraction (Malinow 
and Perley, 1969). 2) A greater excretion of fecal sterols (Gollnick 
and Simmons, 1967). 3) Exercise may cause the preferential release 
of unsaturated fatty acids, thus allowing more rapid plasma transport 
of lipid material and faster mobilization and degradation of hepatic 
cholesterol (Simko, 1970). 4) A long-term exercise program may reduce 
the rate of cholesterolgenesis (Rodionov and Yakubovska, 1968). 5) Ex­
ercise may increase the thyroid secretion rate, resulting in the lower­
ing of serum cholesterol observed with increased thyroxine levels (Naitp, 
1971; Story and Griffith, 1972). 
The interaction between exercise and thyroxine treatment in re­
lation to S-CHOL in this study lends support to the final possible 
mechanism presented above. There was little decrease, or even a slight 
increase, in S-CHOL with exercise in the A and Hy rats of both age 
groups. The findings in the A rats suggest the importance of the intact 
thyroid in the cholesterol lowering effects of exercise, as does the 
results of the Hy groups, since these rats were also thyroidectomized 
before exogenous thyroxine administration rendered them hyperthyroid. 
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However, the results of this study suggest that hyperthyroidism exerts 
its S-CHOL lowering effect by increasing removal of cholesterol. Ex­
ercise did not demonstrate any increase in cholesterol removal in this 
study, as discussed later. 
The inverse relationship between thyroxine and S-CHOL, as found 
in this study, has been well documented (Boyd and Oliver, 1960; 
Kritchevsky, 1960; Myant, 1964; Story and Griffith, 1972; Strisower 
e£ aj^., 1957). A direct relationship, however, between thyroxine and 
cholesterol synthesis has also been demonstrated (Fletcher and Myant, 
1958; Gudner et al., 1968; Kritchevsky, 1960; Long, 1974) and Rosenman 
and Friedman (1956) found no change in cholesterol absorption in the 
thyroidectomized rat. 
It would appear, therefore, that changes in excretion, catabolism 
or tissue exchange of cholesterol must account for the differences in 
S-CHOL with thyroid hormone changes. This is supported by the 
studies of: 1) Byers and Friedman (1973), who found a decreased cata­
bolism of cholesterol into bile acids in thyroidectomized rats; 
2) Hruza et al. (1973), who found a decrease in the fecal excretion and 
turnover between the blood and tissues of cholesterol in thyroidectomi­
zed rats; 3) Simons and Myant (1974), xrfio found increased output of 
neutral steroids and bile acids in patients with familial hyperbeta-
lipoproteinaemia given D-thyroxine, which led them to suggest that 
thyroxine may facilitate the entry of plasma cholesterol into liver 
cells. 
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Cholesterol pools A and B 
Cholesterol pool A (Mj^) essentially includes cholesterol of serum, 
erythrocytes, bile, liver, intestine and some cholesterol of other 
organs like the spleen, kidney and lungs (Bolzano et al., 1973). It 
might be reasoned that the size of (Table 15), or M^/lOOg B.W. 
(Table 16), would reflect similiar changes as that seen in S-CHOL. 
Indeed, the decrease in S-CHOL with exercise is reflected to an extent 
in and M^/lOOg B.W. However, although there is an increase in 
with age, as seen in S-CHOL, this is not seen when calculated as 
MA/lOOg B.W. Even more conflicting is the completely opposite changes 
which take place in M^, and to an extent in M&/100g B.W., with changes 
in thyroxine level, as compared to S-CHOL. 
Much of the cholesterol in however, is not in the serum 
cholesterol. A few calculations indicate that in contrast to man, where 
21 percent of the cholesterol in was found to be serum cholesterol 
(Nestel et a^., 1969), the rat has only about seven percent of as 
serum cholesterol. A larger portion, about 40 percent, of MA. is in 
the rat's liver (Carlson et al., 1968; Kritchevsky et al., 1961). 
The age effects on cholesterol pool A are confusing. The age 
means for indicated a significant increase in with age. However, 
this was due to the larger increase in with hyperthyroidism in the 
mature rats, as the controls did not show increases in with age, but 
instead decreases, although insignificant. Calculated as M^/lOOg B.W. 
the ANOV (Table 16) showed no significant relationship between M^/lOOg 
B.W. and age, although there was a significant decrease in M^/lOOg B.W. 
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in the control rats. A calculation based on dividing by lOOg B,W. is 
questionable, however. Ideally should be divided by the mass of the 
tissues comprising pool A to make valid age comparisons. As an exang)le. 
Long (1974) utilizing the same rats as employed in this study, found a 
lower liver weight to body weight ratio in the mature conçared to the 
young rats. This would indicate that pool A tissue mass does not in­
crease in the same proportion in the mature as in the young rats, thus 
decreasing the difference observed between the young and mature controls. 
It is concluded, therefore, that the age differences in this study con­
stitute no probable change in cholesterol pool A. Considering the large 
proportion of contained in the liver this is partially supported by 
the findings of Carlson et al.(1968), where a significant change in 
hepatic cholesterol was not found between four and nine month old rats. 
Exercise decreased both and M^/lOOg B.W. significantly, accord­
ing to the ANOV, although this effect was not exhibited in the control 
rats for M^/lOOg B.W. (Tables 15 and 16). No significant difference in 
liver weight /lOOg B.W. was found by Long (1974) due to exercise. 
Therefore, considering the large amount of contained in liver 
cholesterol, this finding is supported by that of Monsen et al. (1972), 
who found a decrease in hepatic cholesterol with exercise. The decrease 
in serum cholesterol with exercise would also contribute to its effect 
on M^. 
The significant, direct relationship between thyroxine level and 
is opposite to the changes found for serum cholesterol. Considering 
the differences in liver weight this can be partly explained, since a 
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large portion of is in the rats liver cholesterol. Long (1974) 
reported marked decreases in liver weight/lOOg B.W. with athyroidism 
and marked increases with hyperthyroidism. 
Story (1972) found no change in hepatic cholesterol with athyroidism 
or hyperthyroidism, when expressed as mg/lOOg dry liver; and Naito 
(1971) found an increase in both cases, respectively, when expressed as 
mg/lOOg B.W. If these values had been calculated as total cholesterol 
per liver a marked decrease would have been found with athyroidism and 
an increase with hyperthyroidism. This is reflected in the values found 
for in this study. The values for M&/100g B.W, are a little mis­
leading. If it were possible to calculate this as /tissue mass of 
pool A a larger decrease would be expected with athyroidism and smaller 
increase with hyperthyroidism. It is concluded, therefore, that in 
rats the size of pool A will be lowered with athyroidism and increased 
with hyperthyroidism, reflecting in large part changes in liver 
cholesterol. 
This conclusion is in conflict with that reported by Lehner et al. 
(1972), who found a 13 percent increase in with hypothyroidism in 
the squirrel monkey. This may be a species difference, however, since 
Lehner also found a marked (270 percent) increase in hepatic cholesterol 
with athyroidism in the monkey, which was not exhibited in the rat 
(Naito, 1971; Story, 1972). The liver weights were not reported by 
Lehner. 
In relation to age the mature rats exhibited a greater increase in 
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pool A size with hyperthyroidism than the young rats. This may be due 
to altered sensitivity of some rat tissues to thyroxine with age, as 
suggested by Grad and Hoffinan (1955). This is evidently not due to an 
increased effect on hepatic cholesterolgenesis, however, since Long 
(1974) found no difference in the increase of cholesterolgenesis found 
with hyperthyroidism between young and mature rats. 
Cholesterol pool B (MB) includes the cholesterol in all tissues 
not included in pool A, when a two pool system is used. There is pos­
sibly a third pool of nonexchangeable or very slowly exchangeable 
cholesterol, as suggested by Wilson (1970) in the baboon and found by 
Goodman et aL (1973b)' in a longer human study. The results of this 
study are based on a two pool model, however. 
The age differences involved in this study did not indicate a dif­
ference in pool B size when calculated as Mg/lOOg B.W. (Table 18). 
This is supported by the work of Carlson e^ al. (1968), who found no 
change in the amount of cholesterol in the heart or skeletal muscle of 
four and nine month old rats. 
There was also not.a significant decrease in Mg/lOOg B.W. due to 
exercise according to the ANOV, or the Isd test (Table 18), except in 
the mature Hy group. This is supported by the report of Watt e£ al. 
(1972) where no effect on the cholesterol content of the heart, muscle 
or epididymal fat was found with exercise. 
In the nonexercised rats of both age groups there was a large, and 
significant, increase in Mg/lOOg B.W. with athyroidism. This is sup­
ported by the work of Lehner e^ al. (1972), where a doubling of pool B 
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was observed in the hypothyroid monkey. Exercise in the athyroid groups 
of this study reduced the increase in Mg/IOOg B.W. observed, although 
the increase vas still significant in the young rats. 
Hyperthyroidism caused no change in the Mg/lOOg B.W, in the young 
rats. In the mature rats, however, a large increase in Mg/lOOg B.W. 
occurred with hyperthyroidism. The data of this study does not offer 
any satisfactory explanations for this increase. The products of 
Mg X kg^, which give the approximate amounts of cholesterol 
exchanged, do not illustrate an excess of cholesterol being left in 
pool B. The production rate of new cholesterol into pool A (PR^) is 
slightly greater in the mature Hy rats than in the young, however, the 
excretion rate is also increased. It must also be kept in mind, how­
ever, that Mg is a minimal value. The calculation is made possible 
only when values of zero are placed on the synthesis of cholesterol 
by the tissues of pool B and on the loss of cholesterol from pool B. 
Production rate of cholesterol 
PR^ is the production rate of new cholesterol entering pool A 
each day, exclusive of that recycled from it. If it is assumed that 
cholesterol is only excreted from the body through pool A, the PR^ is 
also equal to the metabolic turnover rate. 
The ANOV for PR^/lOOg B.W. does not indicate a significant effect 
of age (Table 20). However, there is a significant reduction in PR^ 
with age when only the control rats are compared. This effect is likely 
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to be due, in part at least, to the decrease in hepatic cholesterol-
genesis with age illustrated in the same rats by Long (1974); and Trout 
et al. (1962) and Yamamoto and Yamamura (1971) in other studies. 
Looking at PR^ as the metabolic turnover rate this finding of a decrease 
in turnover rate with age is supported by the report of Hruza and 
Wachtlova (1969), where a decrease in the metabolic turnover rate of 
cholesterol with age was also found. 
Exercise was not found to significantly affect the PR^/lOOg B.W., 
except in the Hy rats (Table 20), where a decrease occurred with ex­
ercise. Long (1974% likewise, did not find a significant effect of 
exercise on hepatic cholesterolgenesis except in the young Hy group, 
where a decrease occurred. 
The highly significant effect of thyroxine treatment on PR^ and 
PR^/lOOg B.W. in the ANOV (Tables 19 and 20) is due to a decrease in 
athyroidism and an increase in hyperthyroidism. Long (1974) showed a 
similar pattern with changes in hepatic cholesterolgenesis, which is 
supported by Kritchevsky (1960). The decrease in with athyroidism 
is supported by an even larger decrease occurring in hypothyroid monkeys 
(Lehner et al., 1972). This decrease in PR^ also reflects the smaller 
dietary intake of cholesterol in athyroidism, demonstrated by the re­
duced feed intake of athyroid rats (Naito, 1971). Looked at as meta­
bolic turnover rate the findings of this study are supported by the 
report of Hruza (1971b), where a decrease in cholesterol turnover oc­
curred in the thyroidectomized young rats, with the opposite occurring with 
thyroxine administration. 
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Rate constants and metabolic clearance of cholesterol 
The rate constants and kg^ are for the rate of transfer of 
cholesterol from pool A to B and from pool B to A, respectively. 
Although there was a significant increase in k^g with age (Table 
21) in the exercised control rats and an increase approaching sig­
nificance in the nonexercised controls, the overall effect of age on 
k^g was not significant in the ANOV. These effects in controls, how­
ever, indicate an increase in the transfer of cholesterol from pool A 
to B. There were not significant changes in kg^ with age (Table 22), 
although the means show a very slight decrease with age in the control 
rats. Considered together the two rate constants indicate a slightly 
greater tendency for cholesterol to remain in pool B with age in the 
control rats. This finding is also supported by Hruza and Wachtlova's 
(1969) report of decreased turnover of cholesterol between blood and 
tissues with age. 
Exercise, as enqiloyed in this study, did not significantly affect 
either k^g or k^ in the control rats, although both rate constants 
were increased with exercise in the A and Hy groups of both ages except 
for kg^ in the young Hy rats. This may indicate a possible overall 
increase in the turnover rate between the two pools with exercise, how­
ever, with no changes found in the control rats this would be question­
able. 
The thyroxine treatment means for k^g and kg^ indicate opposite 
trends. Athyroidism causes an apparent increase in k^g and a decrease 
in kgA (Tables 21 and 22). Hyperthyroidism, on the other hand, causes 
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an apparent decrease in and an increase in However, the in­
dividual group means, shown in the same tables, show some discrepancies 
from these trends, which are pointed out in the results section. There­
fore, the conclusion which follows must be viewed with reservation until 
further research can possibly clear the point. 
It appears that with athyroidism there is a greater rate of 
cholesterol movement into pool B than out, as compared to controls; 
with the opposite, a greater rate for cholesterol movement out of 
pool B, occurring in the hyperthyroid rats, as compared to the controls. 
This is only a mathematical derivation involving hypothetical pools, 
however. 
The findings of this study do not completely agree with those of 
Lehner £t al. (1972) concerning k^g and k^, where decreases in both 
were found with hypothyroidism in the monkey. 
The rate constant k^ is for the total rate of removal of 
cholesterol from pool A- This constant includes both k^g, which has 
been discussed, and k^. The values r^ and r^/lOOg B,W. are expressions 
for the amount of cholesterol removed from pool A per day and are re­
lated to k^ in-that, r^ = k^ x The metabolic clearance percentage 
(MCP) is the percent of serum which is cleared each day of cholesterol. 
Its calculation is explained in Appendix C. Since k^, r^, r^/lOOg B.W. 
and MCP are all related to the removal of cholesterol from pool A 
they will be discussed together. 
With age there appears to be a decline in the removal of cholesterol 
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from pool A. The age means for (Table 24) indicate this, although 
the control rats of the two age groups do not show a difference. When 
calculated as r^ (Table 25), however, there is a decline in removal in­
dicated in the control rats and when a correction is made for body 
weight in r^ to r^/lOOg B.W. (Table 26) there is a significant decline 
in removal of cholesterol per day from pool A in the mature control 
rats. This decline in removal rate with age is also shown by the con­
trol rats in MCP (Table 28). The decline in removal of cholesterol 
with age is of about 30 percent for both r^/lOOg B.W. and MCP. 
The decrease in removal rate of cholesterol with age found in this 
study is supported by the findings of Hruza and Zbuzkova (1973). They 
found a larger (70 percent) decrease in "clearance" of cholesterol with 
age, however, the age difference was greater (90 day and 420 day old 
rats) than in this study, Hruza and Zbuzkova found that this decrease 
in cholesterol excretion with age occurs in both the bile and intestinal 
secretion of cholesterol,,with a more pronounced decrease in the steriod 
than the bile acid fraction of bile. They suggested that hormone 
changes with age, or more likely other blood properties, eq, tighter 
binding of cholesterol to blood lipoproteins, may be responsible for 
the decreased excretion of cholesterol with age. 
Rosenman and Shibata (1952) and Yamamoto and Yamamura (1971) have 
also reported decreased cholesterol excretion in bile and feces with 
age. 
Exercise did not appear to affect the removal of cholesterol from 
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pool A. This was indicated by the nonsignificant effect of exercise on 
k^, r^/lOOg B.W. and MCP in the ANOV for each (Tables 24, 26, and 28). 
There were also no significant differences due to exercise shown in 
the control rats of either age for k^, r^/lOOg B.W. or MCP. 
In total, exercise did not influence the removal of cholesterol 
from pool A, change the hepatic cholesterolgenesis significantly (Long, 
1974) or change the PR^. Therefore, the decrease in S-ŒOL would appear 
to be due to some other mechanism than increased excretion or decreased 
cholesterol synthesis. It is possible, however, that the exercise 
methods employed in this study were not sufficient to demonstrate these 
mechanisms, or the two-pool analysis method is not accurate enough to 
detect the changes. 
A direct relationship between thyroxine level and the rate of re­
moval of cholesterol from pool A was indicated for k^, r^, r^/lOOg B.W, 
and MCP in the means and ANOV for each (Tables 24 - 27). The decrease 
due to athyroidism was 25 percent for MCP and 17 percent for r^/lOOg 
B.W., compared to controls; while the increase with hyperthyroidism was 
about 140 percent for both r^/lOOg B.W. and MCP. The lower k^ value 
with athyroidism in this study is supported by a similar finding by 
Lehner et al^. (1972) in hypothyroid monkeys. 
These findings support those of Byers and Friedman (1973), Hruza 
et al. (1973), and Simons and Myant (1974), as outlined in the discus­
sion on total serum cholesterol, that the inverse relationship of 
thyroxine on serum cholesterol concentrations is due, in part at least, 
to the direct relationship of thyroxine on cholesterol excretion. 
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SUMMARY 
The effects of age, exercise and thyroid status on several cardio­
vascular parameters and cholesterol turnover pools were investigated in 
male rats in two related studes. Rats were divided into young (70 
days of age) and mature (200 days of age) age groups. Each age group 
was subdivided into exercise and nonexercise subgroups. The exercise 
program consisted of swimming the rats to a state of exhaustion five 
days/week for 10 weeks. In the cardiovascular study each subgroup was 
divided into five thyroid treatment groups. The five groups were a 
control group, an athyroid group composed of thyroidectomized rats 
receiving no exogenous L-T^, a hypothyroid group composed of thyroid­
ectomized rats receiving 0.5 ttg'L-T^/lOOg body weight/day, a hyper-
thyroid group composed of thyroidectomized rats receiving 3.5 ng L-T^/ 
lOOg body weight/day and a "pharmacologically" hyperthyroid group com­
posed of thyroidectomized rats receiving 14 Hg L-T^/lOOg body weight/ 
day. In the cholesterol study only three thyroid treatment groups were 
used. These three included the control and athyroid groups, as described 
abov^ and a hyperthyroid group composed of thyroidectomized rats re­
ceiving 7Hg L-T^/lOOg body weight/day. 
At the end of the 10-week experimental period in the cardio­
vascular study the rats were anesthetized, surgically operated on and 
blood pressure and abdominal aortic blood flow measurements were made. 
The heart rate and heart weight determinations were also conducted. 
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Results of this study were as follows: 
1) Final body weight was decreased by exercise, athyroidism and 
hyperthyroidism. The mature rats exhibited a reduction in body weight 
due to hyperthyroidism at a lower thyroxine dose than young rats. 
2) The heart weight was increased by exercise and hyperthyroidism, 
while it was decreased by athyroidism. 
3) Heart rate was decreased by exercise and athyroidism, while 
it was increased by hyperthyroidism. 
4) Blood flow was increased by exercise and hyperthyroidism, 
while it was decreased by athyroidism. No increase with exercise in 
the athyroid rats occurred, while exogenous thyroxine appeared to in­
crease the response of blood flow to exercise. The mature rats ex­
hibited an increase in blood flow due to hyperthyroidism at a lower 
thyroxine dose than the young rats. 
5) Blood pressure was decreased with age and athyroidism, while 
it was increased with hyperthyroidism. Exercise slightly lowered 
blood pressure. 
6) Peripheral resistance was decreased with age, exercise and 
hyperthyroidism, while it was increased with athyroidism. 
During the 10-week experiment period in the cholesterol study 
radioactive cholesterol was intravenously injected and blood samples 
were drawn at periodic intervals until the experiment's termination. 
The cholesterol decay curve was analyzed using a two-pool turnover 
model. 
Results of this study were as follows: 
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1) Total serum cholesterol was increased with age and athyroidism, 
while it was decreased with exercise and hyperthyroidism. 
2) Cholesterol pool A, the rapid turnover pool, was decreased 
by exercise and athyroidism, while it was increased by hyperthyroidism, 
3) Cholesterol pool B, the slow turnover pool, was increased by 
athyroidism. In the young rats hyperthyroidism resulted in no change 
in pool B, while the mature rats exhibited an increase in pool B. 
4) The production rate of cholesterol, also expressed as the 
metabolic turnover rate, was decreased in the control rats with age. 
It was also decreased by athyroidism and increased by hyperthyroidism. 
5) The cholesterol rate constants indicated a tendency for 
cholesterol to remain in pool B with age and athyroidism, while the 
opposite occurred with hyperthyroidism. 
6) The clearance of cholesterol from the body via pool A was 
decreased with age and athyroidism, while it was markedly increased 
with hyperthyroidism. 
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APPENDIX A: THYROIDECTCMY 
Thyroidectomies were performed one week prior to the beginning 
of the experimental period. The basic procedure is outlined in 
D'Amour and Blood's (1954) lab manual, however, several modifications 
were implemented. 
The rats were anesthetized and maintained with ether. A ventral 
mid-line incision was made through the skin of the neck. The sub­
cutaneous glands and overlying muscles were carefully separated, not 
cut, and the opening was widened with a retractor to expose the trachea. 
The thyroid is the reddish, bi-lobed gland lying on either side of the 
trachea just below the larynx. 
Using a pointed probe with a small, sharp hook on the end, locate 
the dorsal edge of one lobe of the thyroid, hook it and lift it straight 
up. Fasten onto it firmly with a pair of fine curved forceps and, while 
keeping tension on it, use the back curved edge of the hooked probe to 
gently, but quickly, free the underside of the thyroid from the trachea. 
Care must be taken not to damage the recurrent laryngeal nerve, 
which lies below the lobe of the thyroid, or respiratory problems may 
develop later. When the lobe is free remove it and quickly place a small 
cotton pellet onto the wound to stop the bleeding. The procedure is 
repeated for the other lobe and the thyroid isthmus is stripped free if 
it still remains. 
When the bleeding has stopped, remove the cotton pellets, and close 
the muscles back into place with a single suture. Close the skin 
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incision with wound clips. Give the animals a one percent solution of 
calcium gluconate for drinking water for one week to help prevent 
parathyroid tetany. 
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APPENDIX B; L-THYROXINE PREPARATION 
1. Weigh 73 mg L-thyroxine^ (sodium salt) and place it in a one 
liter volumetric flask. 
2. Add 300 ml IN sodium hydroxide (NaOH) and stir until the 
L-thyroxine is dissolved. 
3. Add 600 ml distilled water. Next add in HCl (drop by drop) 
until a fine precipitate forms. Adjust pH to 5 with IN HCl. 
4. Bring the final volume to one liter with distilled water. 
The concentration of the stock solution is 70 ug L-thyroxine/ 
ml. The stock solution may be refrigerated for several 
months. 
5. To prepare L-thyroxine for injection, add IN NaOH (drop by 
drop) until the solution clears. Activated L-thyroxine is 
unstable and should be discarded after 48 hours. 
^General Biochemicals, Chagrin Falls, Ohio. 
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APPENDIX C: CHOLESTEROL TURNOVER, CURVE ANALYSIS 
From each blood sample taken the total serum cholesterol and 
duplicate counts/min of radioactive cholesterol were determined. The 
turnover curve of serum cholesterol for each rat was semilogarithmically 
plotted by the computer using this information as, the log of the dis­
integrations per minute per milligram of cholesterol (dpm/mg) vs the 
time in days. A typical turnover curve is shown in Figure 7. 
As shown in the figure the analysis is done by extrapolating the 
terminal linear portion of the turnover curve back to zero time, 
providing the intercept Cg and the value p from the slope of this line. 
From each experimental point measured during the first 10 days the 
value of the corresponding point on the extrapolated line was then 
subtracted, and the difference values so obtained were plotted 
semilogarithmically to obtain a straight line with a slope of CL and a 
y intercept of C^ (Goodman and Noble, 1968). 
Gurpide et al^. (1964) presented a detailed discussion of the kinetic 
analysis of the two-pool system, which can be characterized by the 
in which a equals specific activity in pool A; C^, Cg, a and 3 are the 
values described earlier; e is the base of the natural logarithms; and 
t equals time. Based on this equation a computer program had previously 
been developed by the Animal Science Department at Iowa State University 
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Figure 7. A typical turnover curve of serum cholesterol in a control-
nonexercised-young rat 
Synthesis Absorption Synthesis 
Figure 8. The basic two-pool model 
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by using a least squares method of determination. This program was 
adapted and used in this study to calculate C^, Cg, Ct, and g as a check 
against the hand calculations. The two methods agreed in values. 
Shown in Figure 8 is the two-pool model modified from Bolzano 
et al. (1973), Goodman and Noble (1968), and Wilson (1970). 
The following calculations were made: 
1) = IBW X 8.8x10^, where R equals the amount of 
isotope injected into pool A 
(dpm), at 4uC:/100g IBW. 
IBW equals injected body 
weight. 
2) = fiA , , where equals size of 
pA ('B cholesterol pool A (mg), 
which includes cholesterol of 
plasma, erythrocytes, bile, 
liver, intestine and some 
cholesterol of the spleen, 
kidney and lung. 
-a I^ Ca - BMaCb 
3) k = where equals the rate 
^ % constant ( /day) of total 
removal of cholesterol from 
pool A. 
4) k^ = (a + p + k^), where kg^ equals the rate 
constant ( /day) of transfer 
of cholesterol from pool B to 
pool A, if kg is assumed to 
be zero. 
5) PR. = , where PR  ^ equals the rate of 
aCg + PCa introduction (mg/day) of new 
cholesterol into pool A, and 
metabolic turnover rate if kg 
is assumed to be zero. 
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-f BÂ 
where equals the rate 
constant ( /day) of ex-
excretion of cholesterol 
from pool A, and the whole 
body, if kg is assumed to 
be zero. 
7) = -^AA - ^A' where equals the rate 
constant ( /day) of transfer 
of cholesterol from pool A 
to B. 
8) r* = k^ X 
^AB = ^ AB ^  "A' 
10) Mr = lAB_ 
BA 
PR 
II) MCR = A , 
S-CHOL 
12) MCP = MCR X 100 
serum volume 
where r^ equals the rate of 
loss (mg/day) of cholesterol 
from pool A, if kg is assumed 
to be zero. 
where r^g equals the rate of 
transfer (mg/day) of cholesterol 
from pool A to B. 
where Mg equals the size of 
cholesterol pool B (mg), which 
includes all tissues not in 
pool A. This is minimum pool 
B size, calculated assuming 
no synthesis of cholesterol 
by the tissues of pool B. 
where MCR equals metabolic 
clearance rate of cholesterol 
from pool A, expressed as a 
volume of serum (ml). 
where MCP equals metabolic 
clearance percentage of serum 
"cleared" of cholesterol per 
day. The serum volume was 
calculated on the assumption 
that the average serum volume 
of the rat is about three per­
cent of his body weight 
(Kritchevsky et al^., 1961). 
